Tokushima University / Educator and Researcher Directory --- Goto, Masakazu

Personal Web Page

https://researchmap.jp/m-goto.2020 (researchmap)

Field of Study

Subject of Study

Book / Paper

Book:

1.	湯浅康弘, Hiroshi Okitsu, Masakazu Goto, 枝川広志, Risa Ohmori, 谷亮太郎, 増田有理, 蔵本俊輔, 松本大資, 富林敦司, 浜田陽子, Ruriko Yamashita, 藤井義幸 and Kouji Itou : [A case of gastric cancer in which grade 2 treatment effects were obtained with preoperative two-week S-1 administration]., 株式会社癌と化学療法社, Tokyo, May 2015. (Summary) In our hospital, a clinical trial on the effects of preoperative 2-week S-1 administration for advanced gastric cancer is being conducted. A7 5-year-old man presented to our hospital with a type 2 tumor(poorly differentiated adenocarcinoma)in the pyloric antrum. Subpyloric lymph node enlargement and a c-T2(MP), N1, M0, Stage II A tumor (according to the gastric cancer handling agreement, 14th edition)were diagnosed, and S-1(100mg/day)was subsequently administered for 14 days. On day 15, we performed laparoscopy-assisted distal gastrectomy, with D2 dissection. Analysis of the resected specimen, ie the primary tumor and metastatic lymph nodes, confirmed the effect of the treatment as Grade 2, and revealed a type 2 gastric cancer of 30×20mm in size; this tumor was downstaged to yp-T1b(SM), N1, Stage I B. No adverse events associated with perioperative S-1 were observed, and the postoperative course was good. At the latest follow-up(6 years after treatment), no recurrence was observed. (Keyword) Adenocarcinoma / Aged / Antimetabolites, Antineoplastic / Drug Combinations / Gastrectomy / Humans / Lymph Node Excision / Male / Neoadjuvant Therapy / Neoplasm Staging / Oxonic Acid / Stomach Neoplasms / Tegafur (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25981663 ● Search Scopus @ Elsevier (PMID): 25981663 (PubMed: 25981663)

Academic Paper (Judged Full Paper):

1.	Akinari Kasai, Jinsei Miyoshi, Yasushi Sato, Koichi Okamoto, Hiroshi Miyamoto, Takashi Kawanaka, Chisato Tonoiso, Masafumi Harada, Masakazu Goto, Takahiro Yoshida, Akihiro Haga and Tetsuji Takayama : A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma., Scientific Reports, Vol.14, No.1, 2039, 2024. (Summary) No clinically relevant biomarker has been identified for predicting the response of esophageal squamous cell carcinoma (ESCC) to chemoradiotherapy (CRT). Herein, we established a CT-based radiomics model with artificial intelligence (AI) to predict the response and prognosis of CRT in ESCC. A total of 44 ESCC patients (stage I-IV) were enrolled in this study; training (n = 27) and validation (n = 17) cohorts. First, we extracted a total of 476 radiomics features from three-dimensional CT images of cancer lesions in training cohort, selected 110 features associated with the CRT response by ROC analysis (AUC ≥ 0.7) and identified 12 independent features, excluding correlated features by Pearson's correlation analysis (r ≥ 0.7). Based on the 12 features, we constructed 5 prediction models of different machine learning algorithms (Random Forest (RF), Ridge Regression, Naive Bayes, Support Vector Machine, and Artificial Neural Network models). Among those, the RF model showed the highest AUC in the training cohort (0.99 [95%CI 0.86-1.00]) as well as in the validation cohort (0.92 [95%CI 0.71-0.99]) to predict the CRT response. Additionally, Kaplan-Meyer analysis of the validation cohort and all the patient data showed significantly longer progression-free and overall survival in the high-prediction score group compared with the low-prediction score group in the RF model. Univariate and multivariate analyses revealed that the radiomics prediction score and lymph node metastasis were independent prognostic biomarkers for CRT of ESCC. In conclusion, we have developed a CT-based radiomics model using AI, which may have the potential to predict the CRT response as well as the prognosis for ESCC patients with non-invasiveness and cost-effectiveness. (Keyword) Humans / Esophageal Squamous Cell Carcinoma / Artificial Intelligence / Bayes Theorem / Esophageal Neoplasms / Radiomics / Prognosis / Chemoradiotherapy / Tomography, X-Ray Computed (Tokushima University Institutional Repository) ● Metadata: 119113 (Link to Publication Site) ● Publication site (DOI): 10.1038/s41598-024-52418-4 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38263395 ● Search Scopus @ Elsevier (PMID): 38263395 ● Search Scopus @ Elsevier (DOI): 10.1038/s41598-024-52418-4 (Tokushima University Institutional Repository: 119113, DOI: 10.1038/s41598-024-52418-4, PubMed: 38263395)
2.	Seiya Inoue, Masakazu Goto, Takashi Shono, Haruka Takasugi, Satoshi Fujiwara and Hiromitsu Takizawa : Therapeutic Strategy for Chylothorax After Esophagectomy: Lymphangiography with an Inguinal Intranodal Approach, The Indian Journal of Surgery, Vol.85, No.6, 1421-1426, 2023. (Link to Publication Site) ● Publication site (DOI): 10.1007/s12262-023-03773-5 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85153283320 (DOI: 10.1007/s12262-023-03773-5, Elsevier: Scopus)
3.	Shin Kondo, Tatsuro Inoue, Takashi Saito, Takashi Fujikawa, Motomu Kamada, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Nori Sato, Rei Ono, Toshihiro Akisue, Shinsuke Katoh, Hiromitsu Takizawa and Tetsuya Matsuura : Impact of postoperative physical activity on the development of pneumonia in the subacute phase after esophagectomy in patients with esophageal cancer: A retrospective cohort study, European Journal of Oncology Nursing, Vol.62, 2023. (Summary) Physical activity is important to improve recovery following surgery. This study investigated the impact of physical activity on the development of pneumonia after radical esophagectomy in patients with thoracic esophageal cancer in the subacute phase from postoperative day 11 to hospital discharge. This retrospective cohort study included 83 patients who underwent radical esophagectomy for esophageal cancer between 2016 and 2022. Physical activity was measured using an activity tracker, and the average number of steps between postoperative days 8 and 10 was examined. The primary outcome was pneumonia (Clavien-Dindo classification 2 or higher) developing between postoperative day 11 and hospital discharge. We used the receiver operating characteristic (ROC) curve analysis to calculate the optimal cutoff value of physical activity that can predict the development of pneumonia and define low physical activity. We used logistic regression analysis to investigate the impact of low physical activity on postoperative pneumonia. Pneumonia developed in 10 patients (12.0%) during the observation period. The optimal cutoff value of physical activity for predicting pneumonia was 1494 steps per day (sensitivity: 60.0%, specificity: 89.0%, area under the curve: 0.743). In multivariate analysis, low physical activity was an independent predictor of incident pneumonia [odds ratio: 12.10, 95% confidence interval: 2.21-65.90, p = 0.004], with adjustment for age, gastric tube reconstruction route, and postoperative recurrent nerve palsy. Physical activity following radical esophagectomy in patients with thoracic esophageal cancer was an independent predictor of the development of pneumonia in the subacute phase after radical esophagectomy. (Keyword) Humans / Esophagectomy / Retrospective Studies / Risk Factors / Pneumonia / Esophageal Neoplasms / Postoperative Complications (Tokushima University Institutional Repository) ● Metadata: 119570 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ejon.2023.102270 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36709719 ● Search Scopus @ Elsevier (PMID): 36709719 ● Search Scopus @ Elsevier (DOI): 10.1016/j.ejon.2023.102270 (Tokushima University Institutional Repository: 119570, DOI: 10.1016/j.ejon.2023.102270, PubMed: 36709719)
4.	Mariko Aoyama, Takashi Shono, Tomohiro INUI, Naoki Miyamoto, Shin-ichi Sakamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : Abscopal effect in a patient with solitary extramedullary plasmacytoma of the thyroid: case report, Translational Cancer Research, Vol.11, No.11, 4200-4205, 2022. (Summary) The abscopal effect is a systemic antitumor response that occurs distant to the irradiation site and is induced by local irradiation. We herein describe a case of solitary extramedullary plasmacytoma (SEP) of the thyroid in which bone metastases disappeared after thyroidectomy and cervical radiotherapy (RT). A 68-year-old man with a right cervical swelling for approximately 10 years visited a hospital with left elbow pain that persisted for 5 months. He was referred to our hospital for more detailed examinations and treatment. An immobile mass of approximately 10 cm in diameter was palpable on the right side of the patient's neck. Computed tomography (CT) showed osteolytic changes in the left humerus and right scapula, and a tumor in the right lobe of the thyroid gland. The patient was diagnosed with widely invasive follicular carcinoma and multiple bone metastases and underwent total thyroidectomy. During surgery, tumor infiltration into the trachea was observed. Shaving between the tumor and trachea was performed. Based on the results of a pathological examination, the patient was diagnosed with primary extramedullary plasmacytoma of the thyroid. After surgery, external beam RT was performed on the neck, which also reduced the pain in the left elbow. Positron emission tomography (PET)-CT showed the decreased accumulation of fluorodeoxyglucose (FDG) in the left humerus and right scapula, and the amelioration of osteolytic changes on CT. SEP of the thyroid is rare, and to the best of our knowledge, this is the first case report in which the abscopal effect was observed after thyroidectomy and cervical RT. (Link to Publication Site) ● Publication site (DOI): 10.21037/tcr-22-1419 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36523308 ● Search Scopus @ Elsevier (PMID): 36523308 ● Search Scopus @ Elsevier (DOI): 10.21037/tcr-22-1419 (DOI: 10.21037/tcr-22-1419, PubMed: 36523308)
5.	Mariko Aoyama, Tomohiro Inui, Naoki Miyamoto, Shin-ichi Sakamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : A case of papillary thyroid carcinoma with renal and pulmonary metastases, Journal of Surgical Case Reports, Vol.2022, No.8, rjac366, 2022. (Summary) Distant metastases derived from papillary carcinoma are generally detected in the lungs and bones. However, renal metastasis is rare. We herein report a case of papillary thyroid carcinoma with renal and pulmonary metastases that had been initially diagnosed as primary renal carcinoma with pulmonary metastases. The lesions showed response to immune checkpoint inhibitors and tyrosine kinase inhibitor but not to radioactive iodine therapy. (Link to Publication Site) ● Publication site (DOI): 10.1093/jscr/rjac366 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35975227 ● Search Scopus @ Elsevier (PMID): 35975227 ● Search Scopus @ Elsevier (DOI): 10.1093/jscr/rjac366 (DOI: 10.1093/jscr/rjac366, PubMed: 35975227)
6.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, Hiromitsu Takizawa, Akira Tangoku, Hisanori Uehara and Yoshimi Bando : ypN0 in Patients with Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer, Anticancer Research, Vol.42, No.1, 195-203, 2022. (Summary) Histopathological tumor regression grade is applied not to lymph nodes but primary tumors modified by preoperative treatments. This study focused on patients whose pathological examination at the time of surgery showed no residual tumor after chemo(radio)therapy in the primary lesion (ypT0) or lymph nodes (ypN0). A total of 87 patients with clinical stage II/III thoracic esophageal cancer underwent esophagectomy following preoperative treatments to evaluate significances between pathological response and clinical outcomes; 51 patients with clinically definitive lymph node metastasis (cN+) were analyzed as a subgroup. ypT0 rates were 20.7% and 23.5%, and ypN0 rates were 47.1% and 27.5% in the whole cohort and in the cN+ subgroup, respectively. Disease-free survival, from surgery to relapse or death, was significantly influenced by ypN status (p=0.035) but not by ypT status in the 51 patients with definitive cN+ disease. Preoperative chemoradiation was an independent favorable factor for achievement of ypN0 in the 51 patients (odds ratio=0.09; p=0.007). ypN status was a predictive factor for DFS in patients treated with docetaxel plus low-dose 5-fluorouracil and cisplatin combined chemotherapy, superior to ypT status, especially in patients with definitive cN+ disease. (Keyword) Aged / Aged, 80 and over / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy, Adjuvant / Cisplatin / Disease-Free Survival / Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma / Esophagectomy / Female / Fluorouracil / Humans / Lymph Nodes / Lymphatic Metastasis / Male / Middle Aged / Neoadjuvant Therapy / Neoplasm Grading / Preoperative Care (Link to Publication Site) ● Publication site (DOI): 10.21873/anticanres.15473 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34969725 ● Search Scopus @ Elsevier (PMID): 34969725 ● Search Scopus @ Elsevier (DOI): 10.21873/anticanres.15473 (DOI: 10.21873/anticanres.15473, PubMed: 34969725)
7.	Hidenori Maki, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida and Hiromitsu Takizawa : Spontaneous esophageal perforation within a hiatal hernia: A case report, International Journal of Surgery Case Reports, Vol.98, 107484, 2022. (Tokushima University Institutional Repository) ● Metadata: 118024 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ijscr.2022.107484 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85136678999 (Tokushima University Institutional Repository: 118024, DOI: 10.1016/j.ijscr.2022.107484, Elsevier: Scopus)
8.	Shin Kondo, Tatsuro Inoue, Takahiro Yoshida, Takashi Saito, Seiya Inoue, Takeshi Nishino, Masakazu Goto, Nori Sato, Rei Ono, Akira Tangoku and Shinsuke Katoh : Impact of preoperative 6-minute walk distance on long-term prognosis after esophagectomy in patients with esophageal cancer., Esophagus, Vol.19, No.1, 95-104, 2021. (Summary) The preoperative 6MWD is useful for evaluating exercise capacity and predicting the long-term outcome in patients undergoing esophagectomy. (Keyword) Esophageal Neoplasms / Esophagectomy / Humans / Neoplasm Recurrence, Local / Prognosis / Retrospective Studies (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-021-00871-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34383155 ● Search Scopus @ Elsevier (PMID): 34383155 ● Search Scopus @ Elsevier (DOI): 10.1007/s10388-021-00871-9 (DOI: 10.1007/s10388-021-00871-9, PubMed: 34383155)
9.	Akira Tangoku, Hiromitsu Takizawa, Takahiro Yoshida, Masakazu Goto, Seiya Inoue and 都築英雄 : 食道癌手術における高度胸膜癒着症例への対処, Operation, Vol.75, No.7, 1069-1074, 2021. (Keyword) 胸膜癒着 / 食道亜全摘術 / 縦隔鏡下食道切除術 / キョウマクユチャク / ショクドウアゼンテキジュツ / ジュウカクキョウカショクドウセツジョジュツ (Link to Publication Site) ● Publication site (DOI): 10.18888/op.0000002281 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390569932783885568 ● Search Scopus @ Elsevier (DOI): 10.18888/op.0000002281 (DOI: 10.18888/op.0000002281, CiNii: 1390569932783885568)
10.	Takeshi Nishino, Hiroaki Toba, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Naoya Kawakita, Hiromitsu Takizawa, Yoshihiro Tsuruo and Akira Tangoku : Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer, Annals of Surgical Oncology, Vol.28, No.11, 6398-6406, 2021. (Summary) Accurate diagnosis of the tracheobronchial invasion of advanced esophageal cancer is essential to select appropriate treatment and improve prognosis; however, it is difficult using the conventional modalities. This study aimed to clarify the diagnostic usefulness of convex probe endobronchial ultrasound (CP-EBUS) for the diagnosis of the tracheobronchial invasion of advanced esophageal cancer. We conducted a cadaveric study to clarify the changes in ultrasonic and histopathologic findings in the esophageal tumor and tracheal invasion models. Additionally, we examined CP-EBUS for patients with advanced thoracic esophageal cancer in whom tracheobronchial invasion was suspected on contrast-enhanced computed tomography (CE-CT) scan. We retrospectivity evaluated the diagnosis of CP-EBUS, comparing the pathological findings and treatment outcomes. Cadaveric esophageal tumor and tracheal invasion models showed the disappearance of the third layer observed with CP-EBUS and histologically proven interruption of the adventitia. This indicated that the third layer corresponded with the tracheal adventitia. We examined 40 patients with advanced thoracic esophageal cancer in whom tracheobronchial invasion was suspected. The precise diagnosis was pathologically confirmed in 9 of 14 patients diagnosed with cT3 who underwent radical surgery. 20 of 26 cases diagnosed with cT4b received definitive chemoradiotherapy, and 4 cases received salvage surgery and pathologically confirmed precise diagnosis. CP-EBUS is extremely useful for diagnosing the tracheobronchial invasion of advanced esophageal cancer. It could be an effective modality for determining treatment strategies in cases with a marginal surgical indication. (Keyword) Bronchoscopy / Endosonography / Esophageal Neoplasms / Humans / Lung Neoplasms / Tomography, X-Ray Computed / Trachea (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-021-09912-0 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33826003 ● Summary page in Scopus @ Elsevier: 2-s2.0-85103949292 (DOI: 10.1245/s10434-021-09912-0, PubMed: 33826003, Elsevier: Scopus)
11.	Masakazu Goto and Mingyao Liu : ASO Author Reflections: CXCR7 and CXCL12 Expression as Biomarker in Patients with Esophageal Adenocarcinoma., Annals of Surgical Oncology, Vol.28, No.9, 4952, 2021. (Keyword) Adenocarcinoma / Biomarkers / Chemokine CXCL12 / Humans (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-021-09807-0 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33811307 ● Summary page in Scopus @ Elsevier: 2-s2.0-85103853903 (DOI: 10.1245/s10434-021-09807-0, PubMed: 33811307, Elsevier: Scopus)
12.	Masakazu Goto, Yukiko Shibahara, Cristina Baciu, Frances Allison, C Jonathan Yeung, E Gail Darling and Mingyao Liu : Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma., Annals of Surgical Oncology, Vol.28, No.9, 4943-4951, 2021. (Summary) High CXCR7 expression was associated with poor prognosis in patients with EAC, and high expression of CXCR7 with its ligand CXCL12 had a stronger association with prognosis. Further study of this potential biomarker using whole tissue samples and a larger sample size is warranted. (Keyword) Adenocarcinoma / Chemokine CXCL12 / Esophageal Neoplasms / Humans / Lymphatic Metastasis / Prognosis / Receptors, CXCR / Receptors, CXCR4 (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-021-09775-5 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33709176 ● Search Scopus @ Elsevier (PMID): 33709176 ● Search Scopus @ Elsevier (DOI): 10.1245/s10434-021-09775-5 (DOI: 10.1245/s10434-021-09775-5, PubMed: 33709176)
13.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Mariko Aoyama, Naoya Kawakita, Yota Yamamoto, Yoshihito Furukita, Hiromitsu Takizawa and Akira Tangoku : Biomarkers predicting the response to chemotherapy and the prognosis in patients with esophageal squamous cell carcinoma., General Thoracic and Cardiovascular Surgery, Vol.69, No.3, 525-533, 2021. (Summary) The prognosis of patients with esophageal squamous cell carcinoma (ESCC) has been improved by multidisciplinary therapy with chemoradiotherapy and surgery, but it remains poor. Advanced stage, malignant potential, and chemo-resistance contribute to the poor prognosis. Here, we attempted to identify predictive factors of the response to chemotherapy and the prognosis of ESCC patients. We examined 51 ESCC patients who were treated with chemotherapy followed by radical surgery, and 23 patients who were treated with chemotherapy alone. We conducted quantitative reverse transcription-polymerase chain reaction gene expression analysis using RNA extracted from 74 tumor tissue samples collected before chemotherapy and 67 tumor tissue samples collected after chemotherapy, focusing on PIK3CA, AKT-1, mTOR, 4E-BP1, p70S6K, PD-L1, and PD-L2. The proportions of patients with high expressions of AKT-1 and PD-L1 before chemotherapy were significantly higher among the non-responders than among the responders (p = 0.034, p = 0.020, respectively). Multivariate analyses revealed that high PD-L1 expression before chemotherapy was associated with poor response to chemotherapy (odds ratio 2.998; 95% CI 1.043-8.619; p = 0.042) and high p70S6K expression before chemotherapy was a poor prognostic factor (hazard ratio 2.518; 95% CI 1.058-5.988; p = 0.037). In addition, the patients with high expression of PD-L1 and PD-L2 in the tumors after chemotherapy had significantly worse survival than those with low expression of these genes (p = 0.012, p = 0.007, respectively). These results demonstrated that PD-L1 and p70S6K in the primary ESCC tissues were related to a poor response to chemotherapy and poor prognosis, respectively. (Keyword) Biomarkers, Tumor / Chemoradiotherapy / Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma / Humans / Prognosis (Tokushima University Institutional Repository) ● Metadata: 115936 (Link to Publication Site) ● Publication site (DOI): 10.1007/s11748-021-01586-5 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33449265 ● Summary page in Scopus @ Elsevier: 2-s2.0-85099215910 (Tokushima University Institutional Repository: 115936, DOI: 10.1007/s11748-021-01586-5, PubMed: 33449265, Elsevier: Scopus)
14.	Naoki Miyamoto, Seiya Inoue, Takeshi Nishino, Masakazu Goto, Takahiro Yoshida, Tomoko Kobayashi, Yoshimi Bando, Hiromitsu Takizawa and Akira Tangoku : A CASE OF VAGUS NERVE SCHWANNOMA DIFFICULT TO DISTINGUISH FROM LYMPH NODAL METASTASIS OF ESOPHAGEAL CANCER., The Journal of Medical Investigation : JMI, Vol.68, No.1.2, 205-208, 2021. (Summary) In this report, we describe a rare case of vagus nerve schwannoma associated with esophageal cancer. A 70-year-old man visited our hospital complaining of worsening dysphagia. His upper gastrointenstinal endoscopy revealed a mass in the esophagus. A contrast-enhanced chest computed tomography also detected a 15 mm nodule attached to the tracheal membrane. This nodule was diagnosed as a metastatic lymph node. Although the primary tumor reduced after neoadjuvant chemotherapy, the nodule remained intact ; it showed fluorodeoxyglucose accumulation on positron emission tomography. We had a clinical diagnosis of stage III after neoadjuvant chemotherapy and underwent surgery. Intraoperatively, the nodule could not be detached from the right vagus nerve ; therefore, we excised the nodule along with the adjacent vagus nerve. The nodule was pathologically diagnosed as a vagus schwannoma. The nodule was not a regional lymph node metastasis of esophageal cancer. His postoperative course was uneventful, and he is currently undergoing outpatient follow-up without recurrence. J. Med. Invest. 68 : 205-208, February, 2021. (Tokushima University Institutional Repository) ● Metadata: 116023 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.68.205 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33994473 ● Search Scopus @ Elsevier (PMID): 33994473 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.68.205 (Tokushima University Institutional Repository: 116023, DOI: 10.2152/jmi.68.205, PubMed: 33994473)
15.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Yoshihito Furukita, Yota Yamamoto, Satoshi Fujiwara, Takuya Minato, Hiroyuki Sumitomo, Yasuhiro Yuasa, Hiromitsu Takizawa and Akira Tangoku : The sterno-tracheal distance is an important factor of anastomotic leakage of retrosternal gastric tube reconstruction after esophagectomy, Esophagus, Vol.17, No.3, 264-269, 2020. (Summary) Anastomotic leakage (AL) is a serious complication after esophagectomy. The retrosternal (RS) route has been selected majorly to reduce reflux and related pneumonia and considering mediastinal recurrences. AL has been developed more in RS than posterior mediastinal (PM) route reconstruction. Therefore, we suspected the sterno-tracheal distance (STD) might be related to AL and started the selection according to the STD from 2009. A total of 221 patients who underwent a subtotal esophagectomy with gastric tube reconstruction during January 2004-April 2017 were investigated. The patients were classified into the 'after STD selection' (A; n = 144) group and the 'before STD selection' (B, n = 77) group. The incidences of and the risk factors for AL between the two groups were compared. The incidence of AL was high in the B group (18.2%), and 78.6% of the patients who developed AL were treated with RS route reconstruction. The median STDs of the patients with AL and no AL were 10.3 mm and 14.5 mm, respectively (p = 0.001). These results demonstrated that the STD was a risk factor for AL in the RS route. Based on these results, 13 mm was set as the cutoff value. After STD selection, the median STD increased from 14.0 to 17.3 mm (p = 0.001), and the incidence of AL decreased significantly from 26.2 to 11.1% in the RS route (p = 0.037). The STD was the independent risk factor for AL in the RS route. RS route reconstruction should be avoided for the patients with STD < 13 mm. (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-019-00705-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31776810 ● Summary page in Scopus @ Elsevier: 2-s2.0-85075623295 (DOI: 10.1007/s10388-019-00705-9, PubMed: 31776810, Elsevier: Scopus)
16.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Kouhei Nishioka, Keisuke Fujimoto, Mariko Aoyama, Daisuke Matsumoto, Hiromitsu Takizawa and Akira Tangoku : Safe central venous catheters for esophageal cancer treatment, The Journal of Medical Investigation : JMI, Vol.67, No.3,4, 298-303, 2020. (Summary) Introduction : Central venous catheter (CVC) use is essential for treating esophageal cancer. Peripherally inserted central catheters (PICC) are commonly used recently for improved patient comfort and safety. We compared centrally inserted central catheters (CICC) and PICC insertions and examined their safety. Methods : We retrospectively investigated complications at the catheter insertion and post-insertion for 199 patients' esophageal cancer treatment (CICC : 45, PICC : 154) from 2013 to 2018. In addition, we summarized the results of catheter tip culture. Results : No serious complications occurred at the catheter insertion in either group. The rate of complications at catheter insertion was 5.8% for PICC and 6.7% for CICC patients. Post-insertion complications were observed in 6.5% and 11.1% of patients with PICC and CICC, respectively, and this difference was not significant. The incidence of catheter-related blood stream infection (CRBSI) was significantly lower in PICC than CICC patients (0.3 vs. 1.8 / 1,000 catheter-days ; p = 0.029). Catheter-related thrombosis was observed in PICC : 0.5 and CICC : 0.6, and occlusion due to blood flow reversal was observed in PICC : 0.5 and CICC : 0.6. Conclusion : PICCs are safer and more effective than CICCs for the treatment of esophageal cancer, and reduce the incidence of CRBSI. We hope to standardize the insertion procedures, conventionalize techniques, and establish training systems. J. Med. Invest. 67 : 298-303, August, 2020. (Tokushima University Institutional Repository) ● Metadata: 115428 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.67.298 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33148905 ● Summary page in Scopus @ Elsevier: 2-s2.0-85095590219 (Tokushima University Institutional Repository: 115428, DOI: 10.2152/jmi.67.298, PubMed: 33148905, Elsevier: Scopus)
17.	Masakazu Goto and Liu Mingyao : Chemokines and their receptors as biomarkers in esophageal cancer, Esophagus, Vol.17, No.2, 113-121, 2019. (Summary) Esophageal cancer (EC) is one of the most lethal malignancies of the digestive tract and remains to be improved poor prognosis. Two histological subtypes, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), are major characteristics of EC. Deep understanding about both subtypes is essential to overcome EC. Here, we focus on chemokines and their receptors as biomarkers and their current applications for the prognosis in EC. We reviewed relevant articles identified using PubMed database for the chemokines and their receptors in EC analyzed by immunohistochemistry. The primary objective is to summarize evidences for them as prognostic biomarkers in EC. A total of twenty-one articles were reviewed after exclusion. Most studies have been done in ESCC, and less in EAC. CXCL12 and its receptor CXCR4 have been shown in both subtypes as biomarkers. CXCR7, CXCL8 and its receptor CXCR2, and CCL21 and its receptor CCR7 have been examined in ESCC. Although it was a small number of reports, CXCL10, CCL4, and CCL5 have been indicated to have anti-tumor effects in ESCC. Chemokines and their receptors have the potential to be the biomarkers in EC. Comparative studies between ESCC and EAC will reveal the similarity and difference in these two subtypes of EC. These studies may indicate whether these molecules play important roles in both subtypes or are unique to one or another. (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-019-00706-8 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31773415 ● Summary page in Scopus @ Elsevier: 2-s2.0-85075618546 (DOI: 10.1007/s10388-019-00706-8, PubMed: 31773415, Elsevier: Scopus)
18.	Masakazu Goto, Hiroshi Okitsu, Yasuhiro Yuasa, Shunsuke Kuramoto, Atsushi Tomibayashi, Daisuke Matsumoto, Osamu Mori, Ryotaro Tani, Hiroshi Edagawa and Yuta Matsuo : Thoracoscopic Oesophagectomy Using Prone Positioning for Oesophageal Cancer With Right Aortic Arch: A Case Report., Anticancer Research, Vol.39, No.6, 3207-3211, 2019. (Summary) There exist only a few reports of thoracoscopic oesophagectomy for EC with RAA. Sufficient preoperative preparation and sharing an adequate strategy for the surgical approach with the surgical team are definitely necessary. Although the thoracoscopic approach for EC with RAA is useful, more considerations are needed for some issues. (Link to Publication Site) ● Publication site (DOI): 10.21873/anticanres.13460 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31177169 ● Search Scopus @ Elsevier (PMID): 31177169 ● Search Scopus @ Elsevier (DOI): 10.21873/anticanres.13460 (DOI: 10.21873/anticanres.13460, PubMed: 31177169)
19.	Haruka Takasugi, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Daisuke Matsumoto, Tomohiro Inui, Hiromitsu Takizawa, Hideo Tsuzuki, Toshikatsu Taniki and Akira Tangoku : Acase of advanced colon cancer arising from a colonic graft foran esophago-bronchial fistula : A case report., The Journal of Medical Investigation : JMI, Vol.66, No.1.2, 190-193, 2019. (Summary) Neoplasm of a colonic graft after esophageal reconstruction is rare. We treated a colon cancer patient who developed malignancy in a colonic graft after esophagectomy and reconstruction through a retrosternal route. A male had undergone esophagectomy in his 50s due to a benign esophago-bronchial fistula. His dysphagia became exacerbated 20 years later, and further examinations showed a circumferential tumor on the esophagocolonic anastomosis. He underwent resection of the colonic graft adenocarcinoma with median sternotomy after neoadjuvant chemotherapy. Gastric tube reconstruction was performed through a retrosternal route. This report should be informative in terms of making decisions from an initial reconstruction to follow-up and choosing a therapeutic strategy for colonic graft cancer in the future. J. Med. Invest. 66 : 190-193, February, 2019. (Tokushima University Institutional Repository) ● Metadata: 113422 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.190 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31064939 ● Search Scopus @ Elsevier (PMID): 31064939 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.66.190 (Tokushima University Institutional Repository: 113422, DOI: 10.2152/jmi.66.190, PubMed: 31064939)
20.	Takeshi Nishino, Takahiro Yoshida, Masakazu Goto, Seiya Inoue, Takuya Minato, Satoshi Fujiwara, Yota Yamamoto, Yoshihito Furukita, Yasuhiro Yuasa, Hiromichi Yamai, Hirokazu Takechi, Hiroaki Toba, Hiromitsu Takizawa, Mitsuteru Yoshida, Jun-ichi Seike, Takanori Miyoshi and Akira Tangoku : The effects of the herbal medicine Daikenchuto (TJ-100) after esophageal cancer resection, open-label, randomized controlled trial, Esophagus, Vol.15, No.2, 75-82, 2018. (Summary) Daikenchuto (TJ-100), a traditional Japanese herbal medicine, is widely used in Japan. Its effects on gastrointestinal motility and microcirculation and its anti-inflammatory effect are known. The purpose of this prospective randomized controlled trial was to investigate the effect of TJ-100 after esophagectomy in esophageal cancer patients. Forty patients for whom subtotal esophageal resection for esophageal cancer was planned at our institute from March 2011 to August 2013 were enrolled and divided into two groups at the point of determination of the operation schedule after informed consent was obtained: a TJ-100 (15 g/day)-treated group (n = 20) and a control group (n = 20). The primary efficacy end-points were maintenance of the nutrition condition and the recovery of gastrointestinal function. The secondary efficacy end-points were the serum C-reactive protein (CRP) level and adrenomedullin level during the postoperative course, the incidence of postoperative complications, and the length of hospital stay after surgery. We examined 39 patients because one patient in the TJ-100 group was judged as having unresectable cancer after surgery. The mean age of the TJ-100 group patients was significantly older than that of the control group patients.The rate of body weight decrease at postoperative day 21 was significantly suppressed in the TJ-100 group (3.6% vs. the control group: 7.0%, p = 0.014), but the serum albumin level was not significantly different between the groups. The recovery of gastrointestinal function regarding flatus, defecation, and oral intake showed no significant between-group differences, but postoperative bowel symptoms tended to be rare in the TJ-100 group. There was no significant between-group difference in the length of hospital stay after surgery. The serum CRP level at postoperative day 3 was 4.9 mg/dl in the TJ-100 group and 6.9 mg/dl in the control group, showing a tendency of a suppressed serum CRP level in the TJ-100 group (p = 0.126). The rate of increase in adrenomedullin tended to be high postoperatively, but there was no significant difference between the two groups. TJ-100 treatment after esophageal cancer resection has the effects of prompting the recovery of gastrointestinal motility and minimizing body weight loss, and it might suppress the excess inflammatory reaction related to surgery. (Keyword) Adrenomedullin / Aged / C-Reactive Protein / Defecation / Eating / Esophageal Neoplasms / Esophagectomy / Female / Gastrointestinal Tract / Humans / Length of Stay / Male / Middle Aged / Nutritional Status / Phytotherapy / Plant Extracts / Postoperative Complications / Prospective Studies / Recovery of Function / Serum Albumin / Weight Loss (Tokushima University Institutional Repository) ● Metadata: 115097 (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-017-0601-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29892933 ● CiNii @ National Institute of Informatics (CRID): 1521699229821638272 ● Summary page in Scopus @ Elsevier: 2-s2.0-85038619573 (Tokushima University Institutional Repository: 115097, DOI: 10.1007/s10388-017-0601-9, PubMed: 29892933, CiNii: 1521699229821638272, Elsevier: Scopus)
21.	Masakazu Goto, Takahiro Yoshida, Yota Yamamoto, Yoshihito Furukita, Seiya Inoue, Satoshi Fujiwara, Naoya Kawakita, Takeshi Nishino, Takuya Minato, Yasuhiro Yuasa, Hiromichi Yamai, Hirokazu Takechi, Jun-ichi Seike, Yoshimi Bando and Akira Tangoku : CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, Vol.24, No.3, 832-840, 2017. (Summary) Chemokines and their receptors are known to play important roles in the tumorigenesis of many malignancies. The chemokine CXCL12 and its receptors CXCR4 and CXCR7 were suggested to be involved in cancer invasion and metastasis. The aim of this retrospective study was to evaluate the prognostic impact of the expressions of CXCL12, CXCR4 and CXCR7 in patients with esophageal squamous cell carcinoma (ESCC). We used immunohistochemistry (IHC) and reverse transcriptase-polymerase chain reaction (RT-PCR) to evaluate the expressions of CXCL12, CXCR4, and CXCR7 in ESCC patients' tumor biopsy specimens obtained during preoperative endoscopy or surgery. These results were compared with the patients' clinicopathological parameters and survival. IHC was conducted for 172 patients. High expression of CXCR4 in the cytoplasm and nuclei and that of CXCR7 were associated with poor cause-specific survival (CSS) (P= .002 and .010, respectively). The specimens from 52 of the 172 patients were examined by RT-PCR and quantitative real-time PCR. The expression levels of messenger RNA (mRNA) of CXCR4 and CXCR7 were significantly increased in the tumors compared with normal esophageal mucosae (P < .0001). The expression level of mRNA of CXCR4 was associated with poor recurrence-free survival and CSS (P = .012 and .038, respectively). CXCR4 expression is associated with poor prognosis in patients with ESCC. (Keyword) Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Squamous Cell / Chemokine CXCL12 / Disease-Free Survival / Esophageal Neoplasms / Esophagectomy / Female / gene expression / Humans / Male / Middle Aged / RNA, Messenger / Receptors, CXCR / Receptors, CXCR4 / Retrospective Studies / Survival Rate (Tokushima University Institutional Repository) ● Metadata: 109690 (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-015-4974-5 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26577115 ● Summary page in Scopus @ Elsevier: 2-s2.0-84947424480 (Tokushima University Institutional Repository: 109690, DOI: 10.1245/s10434-015-4974-5, PubMed: 26577115, Elsevier: Scopus)
22.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Takuya Minato, Yoshihito Furukita, Yota Yamamoto, Yasuhiro Yuasa, Hiromichi Yamai, Hirokazu Takechi, Hiroaki Toba, Hiromitsu Takizawa, Mitsuteru Yoshida, Jun-ichi Seike, Takanori Miyoshi and Akira Tangoku : Gender differences in clinicopathological features and prognosis of squamous cell carcinoma of the esophagus, Esophagus, Vol.14, No.2, 122-130, 2017. (Tokushima University Institutional Repository) ● Metadata: 109991 (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-016-0554-4 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-84988359656 (Tokushima University Institutional Repository: 109991, DOI: 10.1007/s10388-016-0554-4, Elsevier: Scopus)
23.	Masakazu Goto, Hiroshi Okitsu, Yasuhiro Yuasa, Shunsuke Kuramoto, Atsushi Tomibayashi, Daisuke Matsumoto, Yuri Masuda, Hiroshi Edagawa, Ryotaro Tani, Osamu Mori and Yuta Matsuo : Short-Term Outcomes of Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer., The Journal of Medical Investigation : JMI, Vol.63, No.1-2, 68-73, 2016. (Summary) The purpose of this study was to investigate the oncologic outcomes of laparoscopic distal gastrectomy (LDG) for advanced gastric cancer (AGC). Between April 2003 and March 2014, LDG was performed for 392 patients, 91 patients (23.2%) had histopathologically diagnosed AGC beyond T2 depth. The clinicopathological features, postoperative outcomes, mortality, morbidity, recurrence rate, and survivals of those patients were reviewed. The TNM stages of the tumor were IB in 26 patients (28.5%), IIA in 20 (21.9%), IIB in 18 (19.7%), IIIA in 13 (14.2%), IIIB in 6 (6.5%), IIIC in 6 (6.5%), and IV in 2 (2.1%). Major morbidity occurred in 14 patients (15.3%), with no postoperative mortality. Median follow-up was 24.5 months; 10 patients developed recurrence during the follow-up period, and 10 patients died, including 6 cancer deaths. The 5-year overall and disease-free survival rates were 76.8% and 72.6%, respectively. By stage, OS/DFS was 92.3%/91.8% in stage IB, 85.4%/85.4% in stage II, and 49.3%/26.9% in stage III. Oncologic outcomes were good in patients with AGC, especially with stage IB-IIB, who underwent LDG. LDG appears to be an effective approach for treating stage IB and II gastric cancer. (Tokushima University Institutional Repository) ● Metadata: 111156 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.63.68 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27040056 ● Search Scopus @ Elsevier (PMID): 27040056 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.63.68 (Tokushima University Institutional Repository: 111156, DOI: 10.2152/jmi.63.68, PubMed: 27040056)
24.	Yasuhiro Yuasa, Hiroshi Okitsu, Masakazu Goto, Yuta Matsuo, Hiroshi Edagawa, Osamu Mori, Ryotaro Tani, Shunsuke Kuramoto, Mayumi Ikeuchi and Atsushi Tomibayashi : Mesh-Airtight-Preperitoneum: a simple method for confirming mesh placement in transabdominal preperitoneal repair of inguinal hernia., The Journal of Medical Investigation : JMI, Vol.63, No.3-4, 270-273, 2016. (Summary) We devised a method for confirming the position of mesh placed during transabdominal preperitoneal repair (TAPP) of an inguinal hernia. The preperitoneum is sufficiently detached, and the mesh is fixed in place as usual. Before completely closing the peritoneum, pressure is applied from outside the body and inside the abdominal cavity to remove as much air as possible from the detached preperitoneum; the peritoneum is then sutured using a V-Loc(TM) closure device so that it does not constrict. By releasing the pressure all at once, the airtightness of the preperitoneum is maintained, and the position of the mesh can be observed through the translucent peritoneum. This method, called Mesh-Airtight-Preperitoneum (MAPP), could become widely used as a simple technique for confirming mesh position in TAPP. J. Med. Invest. 63: 270-273, August, 2016. (Tokushima University Institutional Repository) ● Metadata: 111192 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.63.270 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27644570 ● Search Scopus @ Elsevier (PMID): 27644570 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.63.270 (Tokushima University Institutional Repository: 111192, DOI: 10.2152/jmi.63.270, PubMed: 27644570)
25.	Masakazu Goto, Hiroshi Okitsu, Yasuhiro Yuasa, Yuta Matsuo, Hiroshi Edagawa, Ryotaro Tani, Osamu Mori, Shunsuke Kuramoto, Atsushi Tomibayashi, Michiko Yamashita and Yoshiyuki Fujii : [A Case of Complete Pathological Response in a Patient with Locally Advanced Sigmoid Colon Cancer after FOLFOX IRI Chemotherapy]., Japanese Journal of Cancer and Chemotherapy, Vol.42, No.11, 1431-1434, 2015. (Summary) A 61-year-old man with advanced sigmoid colon cancer was admitted to our hospital. Abdominal computed tomography (CT) revealed locally advanced sigmoid colon cancer, with suspected invasion of the bladder and small intestine. The clinical stage of the disease was T4b, N1, M0, and Stage III a, with wild-type KRAS expression. A transverse colostomy was performed because of the presence of a bowel obstruction. The patient received 4 courses of Leucovorin, 5-fluorouracil, oxaliplatin, and irinotecan (FOLFOXIRI). The size of the tumor and lymph nodes decreased noticeably after chemotherapy and laparoscopic high anterior resection with lymph node dissection. During this phase, the pathological stage of the disease was ypT0, N0, and Stage 0(no viable carcinoma cells, Grade 3). This result suggested that preoperative FOLFOXIRI chemotherapy is a useful regimen for the treatment of locally advanced colon cancer. (Keyword) Antineoplastic Combined Chemotherapy Protocols / Biopsy / Combined Modality Therapy / Humans / Male / Middle Aged / Neoplasm Staging / Sigmoid Neoplasms / Tomography, X-Ray Computed (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26602406 ● Search Scopus @ Elsevier (PMID): 26602406 (PubMed: 26602406)
26.	Masakazu Goto, Akira Tangoku, Hiromitsu Takizawa, Hirokazu Takechi and Yoshihito Furukita : Usefulness of lymphangiography with near infrared fluorescence system in treatment of postoperative chylothorax, Surgery, Vol.76, No.1, 64-67, 2014. (Keyword) 乳び胸 / リンパ管造影 / indocyanine green (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282763058189568 (CiNii: 1390282763058189568)
27.	Hirokazu Takechi, Kazuaki Mawatari, Nagakatsu Harada, Yutaka Nakaya, Megumi Asakura, Mutsumi Aihara, Hiromitsu Takizawa, Masakazu Goto, Takeshi Nishino, Takuya Minato, Yoshihito Furukita, Yota Yamamoto, Yasuhiro Yuasa, Hiromichi Yamai, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : Glutamine protects the small intestinal mucosa in anticancer drug-induced rat enteritis model., The Journal of Medical Investigation : JMI, Vol.61, No.1-2, 59-64, 2014. (Summary) Supportive therapy during chemotherapy has become essential, but effective preventive therapies to gastrointestinal mucosal injury are few. We investigated the efficacy of glutamine in rat anticancer drug-induced enteritis model. In this study, we used twenty male SD rats. They were divided into control, 5-fluorouracil (5-FU) (orally administered at 20 mg/kg day), 5-FU+glutamine (1000 mg/kg/day) and 5-FU+glutamine+fiber and oligosaccharide (GFO(®)) (1000 mg/kg/day) groups. All groups were sacrificed on day 6 and upper jejunums were excised. The jejunal villous height was measured in specimens. IgA level in jejunal washing solution, and serum diamine oxidase activity were also measured. The jejunal villous height was recognized as shorter in the specimen from 5-FU treated rats compared with 5-FU+glutamine treated rats (p<0.001). Serum diamine oxidase activity in 5-FU+glutamine group were significantly superior to that in 5-FU group (p=0.028). IgA level in jejunal washing solution tended to be higher in 5-FU+glutamine group than that in 5-FU group (p=0.076). On the other hand, serum diamine oxidase activity and IgA level in jejunal washing solution showed no significant difference between 5-FU+GFO and 5-FU treatment group. Our results suggest that glutamine showed protective effects on mucosal injury of small intestine in rat anticancer drug-induced enteritis model. (Keyword) glutamine / gastrointestinal toxity / anticancer drug / diamine oxidase / IgA (Tokushima University Institutional Repository) ● Metadata: 109521 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.61.59 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24705750 ● CiNii @ National Institute of Informatics (CRID): 1390001204244693120 ● Summary page in Scopus @ Elsevier: 2-s2.0-84897937797 (Tokushima University Institutional Repository: 109521, DOI: 10.2152/jmi.61.59, PubMed: 24705750, CiNii: 1390001204244693120, Elsevier: Scopus)
28.	Takeshi Nishino, Yota Yamamoto, Mayumi Ikeda, Masami Morimoto, Yoshihito Furukita, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Junichi Seike, Akira Tangoku and Haruo Fujiwara : [Pathological Complete Response in a Case of Advanced Esophageal Cancer Invading Aorta Treated by Preoperative Chemotherapy with Docetaxel and Cisplatin plus 5-FU]., Japanese Journal of Cancer and Chemotherapy, Vol.40, No.5, 643-646, 2013. (Summary) The patient was a 64-year-old man, diagnosed as cStage IVa esophageal cancer invading the aorta with lymph node metastasis. He received combination chemotherapy with docetaxel/cisplatin/5-FU(DFP therapy). After one course, CT and endoscopic examination showed remarkable reduction of the primary lesion and lymph node metastasis. We performed subtotal esophagectomy and gastric tube reconstruction by the retroposterior mediastinum route. The pathological specimen evidenced fibrosis and infiltration of inflammatory cells on almost all layers, but showed no viable malignant cells in the middle thoracic esophagus. Therefore, the pathological effect was judged as Grade 3(pCR). This case suggested that DFP combination chemotherapy may prove to be a useful treatment for advanced esophageal cancer with invasion to other organs. (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23863591 ● Summary page in Scopus @ Elsevier: 2-s2.0-84977280371 (PubMed: 23863591, Elsevier: Scopus)
29.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Masakazu Goto, 西野豪志 and 雅美森本 : 【エキスパートが教える内視鏡外科手術-ポイントとなる解剖の理解】食道の鏡視下手術食道癌に対する鏡視下手術縦隔鏡下食道切除術, Gastroenterological Surgery, Vol.36, No.5, 539-546, 2013.
30.	西野豪志, Yota Yamamoto, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi and Akira Tangoku : 術前化学放射線療法が奏効し喉頭温存手術が可能となった高度進行頸部食道類基底細胞癌の1例, Operation, Vol.67, No.4, 513-516, 2013. (Keyword) 頸部食道癌 / 類基底細胞癌 / 術前化学放射線療法 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521699230614945408 (CiNii: 1521699230614945408)
31.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Masakazu Goto, 西野豪志 and 森本雅美 : 【手術をめぐるがん看護∼意思決定支援から術後リハビリテーション看護まで∼】, Japanese Journal of Cancer Care, Vol.18, No.2, 111-113, 2013. (Keyword) *腫瘍(外科的療法)
32.	池田真由美, Hiromitsu Takizawa, 古川尊子, 西野豪志, Masakazu Goto, Koichiro Kajiura, Yasushi Nakagawa, Yukikiyo Kawakami, Mitsuteru Yoshida, Shoji Sakiyama, Kazuya Kondo and Akira Tangoku : 内科的治療抵抗性の乳児気管支肉芽に対してHo:YAGレーザー焼灼術を施行した1例, The Journal of the Japan Society for Respiratory Endoscopy, Vol.35, No.2, 222, 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204754813696 (CiNii: 1390001204754813696)
33.	Koichiro Kajiura, Yukikiyo Kawakami, 池田真由美, 古川尊子, 森本雅美, 西野豪志, Masakazu Goto, Misako Nakagawa, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Yasushi Nakagawa, Mitsuteru Yoshida, Hiromitsu Takizawa, Yukiko Tadokoro, Shoji Sakiyama, Kazuya Kondo and Akira Tangoku : YAGレーザー使用時の気管支鏡破損の1例, The Journal of the Japan Society for Respiratory Endoscopy, Vol.35, No.2, 228, 2013. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282679731441664 (CiNii: 1390282679731441664)
34.	Yota Yamamoto, Akira Tangoku, 西野豪志, Masakazu Goto, Yoshihito Furukita and Hirokazu Takechi : 【消化器外科看護まるわかりいちからわかる!術前術後ケア・解剖・疾患・治療】, Gastroenterological Surgery Nursing, Vol.18, No.1, 138-150, 2013. (Keyword) 局所解剖学
35.	Yoshihito Furukita, 森本雅美, Masakazu Goto, Yota Yamamoto, Hirokazu Takechi and Akira Tangoku : 胃食道逆流症と左腎癌に対して腹腔鏡下同時手術を施行した1例, Operation, Vol.66, No.12, 1779-1783, 2012. (Keyword) *胃食道逆流(外科的療法,X線診断,合併症) (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523106605546985088 (CiNii: 1523106605546985088)
36.	Yoshihito Furukita, 森本雅美, Masakazu Goto, Yota Yamamoto, Hirokazu Takechi and Akira Tangoku : 腹腔鏡下手術を施行したupside down stomachを呈する食道裂孔ヘルニアの1例, Journal of Japan Surgical Association, Vol.73, No.11, 2813-2818, 2012. (Keyword) *胃軸捻転(合併症,外科的療法,X線診断) (Link to Publication Site) ● Publication site (DOI): 10.3919/jjsa.73.2813 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.3919/jjsa.73.2813 (DOI: 10.3919/jjsa.73.2813)
37.	Masakazu Goto, Akira Tangoku, Yota Yamamoto, 雅美森本, Yoshihito Furukita and Hirokazu Takechi : MEDIASTINOSCOPE-ASSISTED TRANSHIATAL ESOPHAGECTOMY FOR SUPERFICIAL ESOPHAGEAL CANCER DEVELOPED AFTER LEFT THORACOPLASTY : REPORT OF A CASE, Journal of Japan Surgical Association, Vol.73, No.7, 1659-1663, 2012. (Keyword) 癌腫(外科的療法,診断,病理学) / superficial esophageal cancer / thoracoplasty / mediastinoscope (Link to Publication Site) ● Publication site (DOI): 10.3919/jjsa.73.1659 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282679827435520 ● Search Scopus @ Elsevier (DOI): 10.3919/jjsa.73.1659 (DOI: 10.3919/jjsa.73.1659, CiNii: 1390282679827435520)
38.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Masakazu Goto and Masami Morimoto : The New Era of Staging as a Key for an Appropriate Treatment for Esophageal Cancer, Annals of Thoracic and Cardiovascular Surgery, Vol.18, No.3, 190-199, 2012. (Summary) Fluorodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography (CT) have become the gold standard for staging of esophageal cancer by detecting distant metastases, but metastatic lymph nodes are often difficult to diagnose from the size and standardized uptake value (SUV). If we compare the diagnostic performance of endoscopic ultrasonography (EUS), CT, and FDG-PET in staging of esophageal cancer, EUS is the most sensitive method to identify the detection of regional lymph node metastases, whereas CT and FDG-PET are more specific tests. Combination study with CT, EUS and PETCT cannot make a precise diagnosis after neoadjuvant therapy (NAT). A precise staging might be determined by the fine needle aspiration biopsy (FNAB) under EUS and US screening in the neck and the abdomen even after NAT. Indication of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for superficial cancer is sensitive because of difficulty in T1b cancer diagnosis. Detailed examination about vessel invasion and the possibility of residual tumor with dissected specimen will offer an appropriate additional therapy. New strategy like sentinel lymph node (SLN) navigation could supply more information about lymphatic routes and metastatic nodes. SLN navigation with ESD might become a new less invasive strategy for superficial esophageal cancer. (Keyword) Decision Support Techniques / Diagnostic Imaging / Endoscopic Ultrasound-Guided Fine Needle Aspiration / Endosonography / Esophageal Neoplasms / Fluorodeoxyglucose F18 / Humans / Lymphatic Metastasis / Neoplasm Invasiveness / Neoplasm Staging / Patient Selection / Positron-Emission Tomography / Predictive Value of Tests / Prognosis / Radiopharmaceuticals / Sentinel Lymph Node Biopsy / Tomography, X-Ray Computed (Link to Publication Site) ● Publication site (DOI): 10.5761/atcs.ra.12.01926 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22790989 ● CiNii @ National Institute of Informatics (CRID): 1390001204727960320 ● Search Scopus @ Elsevier (PMID): 22790989 ● Search Scopus @ Elsevier (DOI): 10.5761/atcs.ra.12.01926 (DOI: 10.5761/atcs.ra.12.01926, PubMed: 22790989, CiNii: 1390001204727960320)
39.	Masakazu Goto, Shoji Sakiyama, Hiroaki Toba, Koichiro Kenzaki, Kazuya Kondo and Akira Tangoku : A CASE OF CONGENTIAL ESOPHAGOBRONCHIAL FISTULA IN AN ADULT WITH IMPAIRED PULMONARY FUNCTION WHO WAS TREATED USING FISTULECTOMY AND RIGHT MIDDLE AND LOWER LOBECTOMY, Journal of Japan Surgical Association, Vol.73, No.5, 1075-1079, 2012. (Keyword) 気管食道瘻 / 合併症 / 外科的療法 / 病理学 (Link to Publication Site) ● Publication site (DOI): 10.3919/jjsa.73.1075 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204852799872 ● Search Scopus @ Elsevier (DOI): 10.3919/jjsa.73.1075 (DOI: 10.3919/jjsa.73.1075, CiNii: 1390001204852799872)
40.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 【必読イレウスの診断から治療まで】機械的イレウス複雑性または絞扼性イレウスヘルニア嵌頓, Surgery, Vol.74, No.3, 273-278, 2012.
41.	坂本晋一, Koichiro Kajiura, Hiromitsu Takizawa, Yasushi Nakagawa, 池田真由美, 古川尊子, 森本雅美, 西野豪志, Masakazu Goto, Misako Nakagawa, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Mitsuteru Yoshida, Yukikiyo Kawakami, Yukiko Tadokoro, Shoji Sakiyama, Kazuya Kondo, Yoshimi Bando, 岡崎弘泰, Hisatsugu Goto, Yasuhiko Nishioka and Akira Tangoku : Erlotinibでinduction therapyを行ったIIIA期非小細胞肺癌の1手術例, Shikoku Acta Medica, Vol.68, No.5-6, 251-256, 2012. (Keyword) Carcinoembryonic Antigen(血液) (Tokushima University Institutional Repository) ● Metadata: 110365 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697877401472 (Tokushima University Institutional Repository: 110365, CiNii: 1050020697877401472)
42.	Yoshihito Furukita, 森本雅美, Masakazu Goto, Yota Yamamoto, Hirokazu Takechi and Akira Tangoku : Reoperation for recurrence and complications after nissen fundoplication, Journal of Japan Surgical Association, Vol.73, No.3, 527-531, 2012. (Keyword) esophageal hiatal hernia / fundoplication / reoperation (Link to Publication Site) ● Publication site (DOI): 10.3919/jjsa.73.527 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204850918784 ● Search Scopus @ Elsevier (DOI): 10.3919/jjsa.73.527 (DOI: 10.3919/jjsa.73.527, CiNii: 1390001204850918784)
43.	Takuya Minato, Yota Yamamoto, Jun-ichi Seike, Takahiro Yoshida, Hiromichi Yamai, Hirokazu Takechi, Yasuhiro Yuasa, Yoshihito Furukita, Masakazu Goto, Yoshimi Bando and Akira Tangoku : Aldehyde Dehydrogenase 1 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma., Annals of Surgical Oncology, Vol.20, No.1, 209-217, 2012. (Summary) Aldehyde dehydrogenase 1 (ALDH1) and CD44 act as important biomarkers in several solid tumors. However, few studies have examined the relationships between ALDH1 expression and the prognosis and clinical characteristics of esophageal squamous cell carcinoma (ESCC). This study was a retrospective case-control study and included 152 patients with ESCC. A total of 56 patients underwent surgery (OP group), 40 patients received neoadjuvant chemotherapy involving weekly docetaxel plus 5-fluorouracil and low-dose cisplatin (DFP therapy) prior to undergoing surgery (NAC group), and 56 patients received initial systemic DFP therapy (CT group). The ALDH1 and CD44 immunohistochemical expression levels of each tumor were evaluated and compared with the prognosis and clinical characteristics of the ESCC patients. In the OP and NAC groups, multivariate analysis found that ALDH1 was independently associated with postoperative recurrence and prognosis (OP group, P=0.004 and 0.016, respectively; NAC group, P=0.026 and 0.014, respectively). In addition, CD44 was found to be associated with postoperative recurrence in the OP group and prognosis in the NAC group (P=0.024 and 0.047, respectively). Among the ALDH1-negative clinical stage II/III patients, the OP and NAC groups displayed better prognoses than the CT group (P<0.001). However, among the ALDH1-positive clinical stage II/III patients, the OP and NAC groups displayed poorer prognoses than the CT group (P=0.049). ALDH1 was found to be a predictor of postoperative recurrence and prognosis in ESCC, and CD44 might be a predictor of recurrence and prognosis. ALDH1 expression might affect the treatment strategy for ESCC. (Keyword) Aged / Antigens, CD44 / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Squamous Cell / Case-Control Studies / Chi-Square Distribution / Cisplatin / Disease-Free Survival / Esophageal Neoplasms / Esophagectomy / Female / Fluorouracil / Humans / Isoenzymes / Kaplan-Meier Estimate / Male / Middle Aged / Multivariate Analysis / Neoadjuvant Therapy / Neoplasm Recurrence, Local / Proportional Hazards Models / Retinal Dehydrogenase / Retrospective Studies / Taxoids / Tumor Markers, Biological (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-012-2535-8 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22847125 ● Summary page in Scopus @ Elsevier: 2-s2.0-84871802319 (DOI: 10.1245/s10434-012-2535-8, PubMed: 22847125, Elsevier: Scopus)
44.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Masakazu Goto and 森本雅美 : 内視鏡外科医のための微細局所解剖アトラス縦隔鏡を用いた経裂孔的食道切除術, Operation, Vol.66, No.6, 665-673, 2012.
45.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Masakazu Goto, 西野豪志, 森本雅美, 古川尊子, 池田真由美 and 山崎裕行 : 食道癌の姑息的治療(ステント治療，バイパス手術), コンセンサス癌治療, Vol.11, No.2, 103-109, 2012.
46.	Yasuhiro Yuasa, Junichi Seike, Takahiro Yoshida, Hirokazu Takechi, Hiromichi Yamai, Yota Yamamoto, Yoshihito Furukita, Masakazu Goto, Takuya Minato, Takeshi Nishino, Seiya Inoue, Satoshi Fujiwara and Akira Tangoku : Sentinel lymph node biopsy using intraoperative indocyanine green fluorescence imaging navigated with preoperative CT lymphography for superficial esophageal cancer., Annals of Surgical Oncology, Vol.19, No.2, 486-493, 2011. (Summary) Preoperative CTLG visualized the correct number and site of SLNs in surrounding anatomy during routine computed tomography to evaluate distant metastases. Referring to CTLG, SLNs were identified using IGFI, resulting in successful SLN navigation and saving time and cost. This method appears clinically applicable as a less-invasive method for treating superficial esophageal cancer. (Keyword) Aged / Coloring Agents / Esophageal Neoplasms / Esophagectomy / Feasibility Studies / Fluorescence / Follow-Up Studies / Humans / Indocyanine Green / Lymph Node Excision / Lymph Nodes / Lymphatic Metastasis / Lymphography / Middle Aged / Neoplasm Staging / Prognosis / Sentinel Lymph Node Biopsy / Survival Rate / Tomography, X-Ray Computed (Link to Publication Site) ● Publication site (DOI): 10.1245/s10434-011-1922-x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21792510 ● Search Scopus @ Elsevier (PMID): 21792510 ● Search Scopus @ Elsevier (DOI): 10.1245/s10434-011-1922-x (DOI: 10.1245/s10434-011-1922-x, PubMed: 21792510)
47.	Yoshihito Furukita, Masakazu Goto, 西野豪志, 福井康雄, 谷木利勝 and 堀見忠司 : A case of appendiceal mucinous cystadenoma with high serum carcinoembryonic antigen level on which laparoscopic ileocecal resection was performed, Surgery, Vol.73, No.6, 648-652, 2011. (Keyword) 虫垂粘液嚢胞腺腫 / CEA / 腹腔鏡手術 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001288081414144 (CiNii: 1390001288081414144)
48.	Madoka Hamada, Yutaka Nishioka, Takao Nishimura, Masakazu Goto, Yoshihito Furukita, Kazuhide Ozaki, Toshio Nakamura, Yasuo Fukui, Toshikatsu Taniki and Tadashi Horimi : Laparoscopic permanent sigmoid stoma creation through the extraperitoneal route., Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, Vol.18, No.5, 483-485, 2008. (Summary) About 50% of patients who have a permanent stoma experience some degree of parastomal hernia formation. To prevent this complication, the extraperitoneal route is considered to be more effective than the transperitoneal route in the case of open colorectal surgery. This technique also has superiority in avoiding postoperative intestinal obstruction. Although laparoscopic surgery for rectal cancer has not been proved to be as safe as open surgery by a randomized-controlled trial, some studies have shown the equality of long-term results with laparoscopic low anterior resection and laparoscopic abdominoperineal resection. It is anticipated that cases of laparoscopic abdominoperineal resection will increase in the near future. However, a laparoscopic technique for creation of a permanent stoma has hardly been discussed. Most operative procedures for laparoscopic stoma creation have been performed with transperitoneal route, which may cause parastomal hernia and/or intestinal obstruction. This report describes a laparoscopic technique for permanent sigmoid stoma creation through the extraperitoneal approach. (Link to Publication Site) ● Publication site (DOI): 10.1097/SLE.0b013e3181805729 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18936671 ● Search Scopus @ Elsevier (PMID): 18936671 ● Search Scopus @ Elsevier (DOI): 10.1097/SLE.0b013e3181805729 (DOI: 10.1097/SLE.0b013e3181805729, PubMed: 18936671)

Academic Paper (Unrefereed Paper):

1.	住友弘幸, Hiroshi Okitsu, 増田有理, 藏本俊輔, Daisuke Matsumoto, 富林敦司, 浜田陽子, Masakazu Goto, 湯浅康弘, 川中妙子, 石倉久嗣, 木村秀, 阪田章聖, Michiko Yamashita and 藤井義幸 : Epstein-Barr virus-positive gastric cancer with lymph node metastasis : a case report, Tokushima Red Cross Hospital Medical Journal, Vol.19, No.1, 44-48, 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050282812999350400 (CiNii: 1050282812999350400)
2.	Daisuke Matsumoto, 木村秀, 石倉久嗣, 松岡裕, 増田有理, 藏本俊輔, 富林敦司, Masakazu Goto, 浜田陽子, 湯浅康弘, 川中妙子, Hiroshi Okitsu, 阪田章聖, Michiko Yamashita and 藤井義幸 : 長期間自然経過を追えた早期肺癌の1例, Tokushima Red Cross Hospital Medical Journal, Vol.19, No.1, 76-79, 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050001338022642304 (CiNii: 1050001338022642304)
3.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Masakazu Goto, 西野豪志 and 坂本晋一 : 特集食道疾患手術のすべて Ⅱ．悪性疾患の手術 5．縦隔鏡補助下経裂孔的食道切除術, Operation, Vol.67, No.10, 1435-1440, 2013. (Keyword) 食道癌 / 縦隔鏡 / 非開胸食道抜去術 / 縦隔鏡下食道切除術 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1524232505259609728 (CiNii: 1524232505259609728)
4.	Hirokazu Takechi, 坂本晋一, 森下敦司, Masakazu Goto, 西野豪志, Yoshihito Furukita, Yota Yamamoto, Takahiro Yoshida, Jun-ichi Seike, Hiromitsu Takizawa and Akira Tangoku : Two patients managed by palliative care for symptoms due to cervical lymph node recurrence of esophageal carcinoma, Shikoku Acta Medica, Vol.69, No.3,4, 171-174, 2013. (Summary) Our department aggressively performs initial treatment for esophageal carcinoma with multidisciplinary approaches, and not only positively treats patients with recurrence or metastasis but also manages those in an advanced stage by following the wishes of patients and their families as much as possible. However, many patients with esophageal carcinoma develop digestive tract and tracheal problems with progression of the disease, and the palliation of symptoms and continuation of home care often become difficult. In such patients, it is important to secure and maintain the route of hydration and nutrition when oral fluid and food intake becomes difficult, and to control respiratory symptoms for the promotion of home care and palliation of symptoms in the terminal stage. In this report, we present 2 patients managed by palliative care until death while supporting home care by maintaining enteral nutrition using gastrostomy for esophageal narrowing due to cervical lymph node recurrence, and controlling the cough reflex and dyspnea associated with the development of a cervical lymph node-tracheal fistula through morphine hydrochloride administration. (Keyword) Palliative care / Home care / Esophageal carcinoma / Gastrostomy / Morphine (Tokushima University Institutional Repository) ● Metadata: 109632 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122807795712 (Tokushima University Institutional Repository: 109632, CiNii: 1050865122807795712)
5.	Yota Yamamoto, Akira Tangoku, 西野豪志, Masakazu Goto, Yoshihito Furukita and Hirokazu Takechi : 【消化器外科看護まるわかりいちからわかる!術前術後ケア・解剖・疾患・治療】(第2章)消化器の解剖・疾患・術前術後ケア入門 <1-1>食道の解剖生理，疾患，検査・治療, Gastroenterological Surgery Nursing, Vol.18, No.1, 138-150, 2013.
6.	Akira Tangoku, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Masakazu Goto, 西野豪志 and 森本雅美 : Ⅰ食道の鏡視下手術縦隔鏡下食道切除術, Gastroenterological Surgery, Vol.36, No.5, 539-546, 2013.

Review, Commentary:

1.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, H Kashihara and Chie Takasu : Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection., Surgical Endoscopy, Vol.26, No.8, 2240-2246, Aug. 2012. (Summary) Laparoscopy-assisted gastrectomy (LAG) is becoming widely used for early gastric cancer. However, how the curability and long-term prognosis of LAG and open gastrectomy (OG) for early and advanced gastric cancer compare remains unclear. This study assessed short- and long-term outcomes after LAG with lymph node dissection in early and advanced gastric cancer. A total of 332 patients who underwent LAG or OG for early and advanced gastric cancer from January 2001 through December 2010 were reviewed retrospectively. The mean operating time, estimated mean blood loss, number of dissected lymph nodes, and survival rates were compared between LAG and OG for early and advanced gastric cancer. Overall, 47.6% (158/332) of patients underwent LAG; D1, D1+ lymph node dissection was carried out in 77.2%, with D2 dissection in 22.8%. Only one patient required conversion to OG. Comparing LAG and OG with D1, D1+ lymph node dissection for early gastric cancer (EGC), mean operating time was significantly longer, estimated mean blood loss was significantly smaller, and the average number of retrieved lymph nodes was significantly greater with LAG. The rate of specific postoperative morbidity was 17.2% for LAG patients and 25.0% for OG patients, with no postoperative mortality. Survival and recurrence rates were not significantly different. Comparing LAG and OG with D2 lymph node dissection for advanced gastric cancer (AGC), mean operating time was significantly longer and estimated mean blood loss was significantly smaller with LAG, while the average number of retrieved lymph nodes, specific postoperative morbidity and mortality, and survival and recurrence rates were not significantly different. LAG with D1, D1+ lymph node dissection for EGC is safe and equivalent to open gastrectomy in curability. Moreover, LAG with D2 lymph node dissection for AGC is comparable to OG with D2 lymph node dissection with regard to short- and long-term results. (Keyword) 欧文論文 (Link to Publication Site) ● Publication site (DOI): 10.1007/s00464-012-2167-x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22311300 ● Search Scopus @ Elsevier (PMID): 22311300 ● Search Scopus @ Elsevier (DOI): 10.1007/s00464-012-2167-x (DOI: 10.1007/s00464-012-2167-x, PubMed: 22311300)
2.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, H Kashihara and Chie Takasu : The safety and usefulness of the single incision, transabdominal pre-peritoneal (TAPP) laparoscopic technique for inguinal hernia., The Journal of Medical Investigation : JMI, Vol.59, No.3-4, 235-240, 2012. (Summary) The safety and usefulness of the SILS-TAPP (transabdominal pre-peritoneal) procedure remain unclear. The aim of this study was to clarify the safety and usefulness of the SILS-TAPP procedure compared with standard laparoscopic TAPP and TEPP (totally extra-peritoneal pre-peritoneal) procedures. 85 patients underwent laparoscopic inguinal hernia repairs (TEPP, 30 patients; TAPP, 20 patients; SILS-TAPP, 35 patients) from 2007 to 2011. The operative outcomes of the three groups were compared. There was no difference in the patients' characteristics among the three groups. The TEPP Group had a longer operation time. One patient in the SILS-TAPP group had an intraoperative complication. One patient in the TAPP group had a postoperative complication, and one patient had ileus and one had an umbilical hernia in the SILS-TAPP group. The postoperative hospital stay was not significantly different among the three groups. There were no recurrences in the TEPP group, 1 case of recurrence (5.0%) in the TAPP group, and 1 case (2.9%) in the SILS-TAPP group. The present findings show that the SILS-TAPP repair is safe and feasible for the repair of adult inguinal hernia. (Keyword) 欧文論文 (Tokushima University Institutional Repository) ● Metadata: 106026 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.59.235 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23037193 ● Search Scopus @ Elsevier (PMID): 23037193 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.59.235 (Tokushima University Institutional Repository: 106026, DOI: 10.2152/jmi.59.235, PubMed: 23037193)

Proceeding of International Conference:

1.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, INUI Tomohiro, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : The best method of the gastric tube reconstruction after esophagectomy, The International Society for Diseases of the Esophagus (VIRTUAL), Sep. 2022.
2.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto and Akira Tangoku : The sterno-tracheal distance is an important factor of anastomotic leakage of retrosternal gastric tube reconstruction after esophagectomy, The International Society for Diseases of the Esophagus (Virtual), Sep. 2021. (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-019-00705-9 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85075623295 (DOI: 10.1007/s10388-019-00705-9, Elsevier: Scopus)
3.	Masakazu Goto, Yukiko Shibahara, Cristina Baciu, Gail Elizabeth Darling and Mingyao Liu : Prognostic impact of CXCR7 and CXCL12 expression in Patients with Esophageal Adenocarcinoma, The International Society for Disease of the Esophagus (Virtual), Sep. 2021.
4.	Seiya Inoue, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida and Akira Tangoku : Oral PresentationTreatment Strategy of Esophageal Cancer from the Expression of HER2 and EGFR, International Society for Diseases of the Esophagus, Sep. 2018.
5.	Takeshi Nishino, Hiroaki Toba, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : Oral PresentationDiagnostic Utility of Endobronchial Ultrasonography for the Tracheobronchial Invasion of Esophageal Cancer, International Society for Diseases of the Esophagus, Sep. 2018.
6.	Akira Tangoku, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Takahiro Yoshida : The Effects of the Herbal Medicine Daikenchuto(Tj-100) after Esophageal Cancer Resection, Open-Label, Randomized Controlled Trial, Esophagus, Vol.15, No.2, 75-82, Sep. 2018. (Summary) Daikenchuto (TJ-100), a traditional Japanese herbal medicine, is widely used in Japan. Its effects on gastrointestinal motility and microcirculation and its anti-inflammatory effect are known. The purpose of this prospective randomized controlled trial was to investigate the effect of TJ-100 after esophagectomy in esophageal cancer patients. Forty patients for whom subtotal esophageal resection for esophageal cancer was planned at our institute from March 2011 to August 2013 were enrolled and divided into two groups at the point of determination of the operation schedule after informed consent was obtained: a TJ-100 (15 g/day)-treated group (n = 20) and a control group (n = 20). The primary efficacy end-points were maintenance of the nutrition condition and the recovery of gastrointestinal function. The secondary efficacy end-points were the serum C-reactive protein (CRP) level and adrenomedullin level during the postoperative course, the incidence of postoperative complications, and the length of hospital stay after surgery. We examined 39 patients because one patient in the TJ-100 group was judged as having unresectable cancer after surgery. The mean age of the TJ-100 group patients was significantly older than that of the control group patients.The rate of body weight decrease at postoperative day 21 was significantly suppressed in the TJ-100 group (3.6% vs. the control group: 7.0%, p = 0.014), but the serum albumin level was not significantly different between the groups. The recovery of gastrointestinal function regarding flatus, defecation, and oral intake showed no significant between-group differences, but postoperative bowel symptoms tended to be rare in the TJ-100 group. There was no significant between-group difference in the length of hospital stay after surgery. The serum CRP level at postoperative day 3 was 4.9 mg/dl in the TJ-100 group and 6.9 mg/dl in the control group, showing a tendency of a suppressed serum CRP level in the TJ-100 group (p = 0.126). The rate of increase in adrenomedullin tended to be high postoperatively, but there was no significant difference between the two groups. TJ-100 treatment after esophageal cancer resection has the effects of prompting the recovery of gastrointestinal motility and minimizing body weight loss, and it might suppress the excess inflammatory reaction related to surgery. (Keyword) Adrenomedullin / Aged / C-Reactive Protein / Defecation / Eating / Esophageal Neoplasms / Esophagectomy / Female / Gastrointestinal Tract / Humans / Length of Stay / Male / Middle Aged / Nutritional Status / Phytotherapy / Plant Extracts / Postoperative Complications / Prospective Studies / Recovery of Function / Serum Albumin / Weight Loss (Link to Publication Site) ● Publication site (DOI): 10.1007/s10388-017-0601-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29892933 ● Summary page in Scopus @ Elsevier: 2-s2.0-85038619573 (DOI: 10.1007/s10388-017-0601-9, PubMed: 29892933, Elsevier: Scopus)
7.	Yoshihito Furukita, Akira Tangoku, 藤原聡史, 井上聖也, 西野豪志, Masakazu Goto, 湊拓也, Yota Yamamoto, 湯浅康弘, 山井礼道, Hirokazu Takechi, Takahiro Yoshida and Jun-ichi Seike : New Minimal Invasive Strategy for Superficial Esophageal Cancer, 26th International Conference of the Society for Medical Innovation and Technology, Sep. 2014.
8.	Chie Takasu, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Toru Utsunomiya : Simultaneous laparoscopic resection of primary colorectal cancer and metastatic liver tumor., Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
9.	Shinya Morimoto, Mitsuo Shimada, Nobuhiro Kurita, Horohiko Sato, Takashi Iwata, Masanori Nishioka, Tomohiko Miyatani, Kouzou Yoshikawa, Masakazu Goto, 柏原秀也 and Chie Mikami : Laparoscopic surgery after preoperative chemoradiation for advanced lower rectal cancer., Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
10.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Mikami : The utility of standardization of laparoscopy assisted gastrectomy and introduction of telesurgery mentoring system., Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
11.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : Assessment of gastric cancer malignancy based on CD133 and thrombospondin1(THBS1) expression and the role of histone acetylation., Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2012), San Francisco, Jan. 2012.
12.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : Role of thrombospondin1(THBS1) expression in peritoneal metastasis of gastric cancer treated with taxanes., 21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
13.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : Long-term results of laparoscopy assisted gastrectomy for gastric cancer according to Japanese classification of gastric carcinoma (JCGC) stage-comparison with the results of open surgery-., 21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
14.	Masakazu Goto, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, 柏原秀也 and Chie Takasu : Taylor-made therapy for rectal cancer Role of microRNA-223 expression-., 8th International Simposium on Minimal Residual Cancer (ISMRC2011), Osaka, Sep. 2011.
15.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto and 柏原秀也 : Role of thrombospondin 1 (THBS1) expression in peritoneal metastasis of gastric cancer treated with Taxanes., 8th International Simposium on Minimal Residual Cancer (ISMRC2011), Osaka, Sep. 2011.

Proceeding of Domestic Conference:

1.	Satoshi Fujiwara, Hiroyuki Sumitomo, Mariko Aoyama, Naoya Kawakita, Seiya Inoue, Masakazu Goto and Hiroaki Toba : 下部食道噴門側胃切除後に縫合不全を来した1例, 第37回日本内視鏡外科学会総会, Dec. 2024.
2.	Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, Hiroyuki Sumitomo, Mariko Aoyama, Naoya Kawakita and Hiroaki Toba : 食道切除後の再建胃管血流評価における酸素飽和度イメージングの使用経験, 第37回日本内視鏡外科学会総会, Dec. 2024.
3.	Hiroyuki Sumitomo, Naoya Kawakita, Shin-ichi Sakamoto, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : ICGによる胸管造影が有用であった中縦隔腫瘍の1例, 第37回日本内視鏡外科学会総会, Dec. 2024.
4.	Mariko Aoyama, Seiya Inoue, Naoya Kawakita, Hiroyuki Sumitomo, Satoshi Fujiwara, Masakazu Goto and Hiroaki Toba : VANS甲状腺悪性腫瘍手術におけるリンパ節郭清の工夫と手術成績, 第37回日本内視鏡外科学会総会, Dec. 2024.
5.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, Hiroyuki Sumitomo, Mariko Aoyama, Naoya Kawakita and Hiroaki Toba : 胸腔鏡下食道切除術中の下肺静脈損傷に対する鏡視下リカバリー, 第37回日本内視鏡外科学会総会, Dec. 2024.
6.	阿部祐也, Souichiro Sasa, Hiroaki Inoue, 行重佐和香, Tomohiro Inui, Mariko Aoyama, Atsushi Morishita, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 乳房石灰化が特異的な経過を示した乳癌術後ホルモン療法中の1症例, 第34回日本乳癌検診学会学術総会, Nov. 2024.
7.	Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, 行重佐和香, Kazumasa Okumura, Masakazu Goto, Yoshimi Bando and Hiromitsu Takizawa : 精査機関である当院におけるPPV3の検討, 第34回日本乳癌検診学会学術総会, Nov. 2024.
8.	馬場彩花, Mariko Aoyama, 竹原恵美, 藤本啓介, 竹内大平, Shin-ichi Sakamoto, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 原発性副甲状腺機能亢進症と甲状腺乳頭癌が合併した一例, 第86回日本臨床外科学会学術集会, Nov. 2024.
9.	Atsushi Morishita, Mariko Aoyama, 馬場彩花, 竹原恵美, 竹内大平, 藤本啓介, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 術後病理で判明した稀な甲状腺神経鞘腫の1例, 第86回日本臨床外科学会学術集会, Nov. 2024.
10.	Mariko Aoyama, Seiya Inoue, Naoya Kawakita, 馬場彩花, 竹原恵美, 竹内大平, 藤本啓介, Shin-ichi Sakamoto, Naoki Miyamoto, Atsushi Morishita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : VANS甲状腺悪性腫瘍手術におけるリンパ節郭清の工夫と手術成績, 第86回日本臨床外科学会学術集会, Nov. 2024.
11.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 馬場彩花, 竹原恵美, 藤本啓介, 竹内大平, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba and Hiromitsu Takizawa : 地方大学における外科医のタスクシフティング∼特定看護師の役割, 第86回日本臨床外科学会学術集会, Nov. 2024.
12.	Sawaka Yukishige, Hiroaki Inoue, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Masakazu Goto, Hiroyuki Morino, 吉田友紀子, 宮本容子, Yoshie Imai and Hiromitsu Takizawa : Two cases of surveillance using DWIBS in Li-Fraumeni syndrome, 日本人類遺伝学会第69回大会, Oct. 2024.
13.	阿部祐也, Hiroaki Inoue, Sawaka Yukishige, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : 多職種による介入が効果的であった出血を伴う局所進行乳癌の1例, 第21回日本乳癌学会中国四国地方会, Sep. 2024.
14.	藤稿智宏, Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, Sawaka Yukishige, Hiroaki Toba, Masakazu Goto, 広瀬敏幸, Hisanori Uehara and Hiromitsu Takizawa : 乳房超音波検査にてhaloを伴い乳癌が疑われたadenosisの1例, 第21回日本乳癌学会中国四国地方会, Sep. 2024.
15.	馬場彩花, Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, Sawaka Yukishige, Atsushi Morishita, Naoki Miyamoto, 藤本啓介, 竹原恵美, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : 多発肺転移を有するホルモン陽性乳癌に対しエチニルエストラジオールを投与し長期奏功を得た一例, 第21回日本乳癌学会中国四国地方会, Sep. 2024.
16.	馬場彩花, Naoya Kawakita, 竹原恵美, 藤本啓介, 竹内大平, Shin-ichi Sakamoto, Naoki Miyamoto, Hiroyuki Sumitomo, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 左上葉肺癌に対する左上区切除術後に上腸間膜動脈塞栓症を発症し広範小腸切除術を行った一例, 第99回中国四国外科学会総会/第29回中国四国内視鏡外科研究会, Sep. 2024.
17.	遠藤鋭人, Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 馬場彩花, 竹原恵美, 藤本啓介, 竹内大平, Hiroyuki Sumitomo, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後に発症した自己免疫性膵炎の1切除例, 第99回中国四国外科学会総会/第29回中国四国内視鏡外科研究会, Sep. 2024.
18.	Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 馬場彩花, 竹原恵美, 行重佐和香, 竹内大平, 藤本啓介, Tomohiro Inui, Hiroyuki Sumitomo, Naoki Miyamoto, Mariko Aoyama, Hiroaki Inoue, Naoya Kawakita and Hiromitsu Takizawa : 当院における食道癌手術の定型化への取り組みと術後短期成績について, 第99回中国四国外科学会総会/第29回中国四国内視鏡外科研究会, Sep. 2024.
19.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba and Hiromitsu Takizawa : ICG胃管血流評価を意識した食道胃管吻合の取り組み, 第79回日本消化器外科学会総会, Jul. 2024.
20.	髙杉遥, Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, Atsushi Morishita, Hiroaki Toba and Hiromitsu Takizawa : 当科における食道胃接合部癌に対する手術成績の検討, 第79回日本消化器外科学会総会, Jul. 2024.
21.	Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 髙杉遥, 細川暉雄, Atsushi Morishita, Hiroaki Toba and Hiromitsu Takizawa : 当科における術前化学療法+食道切除後の補助療法の現状 ∼ニボルマブとS-1の比較検討∼Adjuvant chemotherapy in patient with neoadjuvant chemotherapy followed esophagectomy, 第79回日本消化器外科学会総会, Jul. 2024.
22.	阿部祐也, Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, Sawaka Yukishige, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : 術前化学療法後に手術を含めた集学的治療を拒否したHER2陽性局所進行乳癌の1例, 第32回日本乳癌学会学術総会, Jul. 2024.
23.	Mariko Aoyama, Hiroaki Inoue, Sawaka Yukishige, Tomohiro Inui, Souichiro Sasa, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 術前診断が困難だった乳腺粘液癌肝転移の1例, 第32回日本乳癌学会学術総会, Jul. 2024.
24.	Tomohiro Inui, Hiroaki Inoue, 細川暉雄, Sawaka Yukishige, Souichiro Sasa, Mariko Aoyama, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当院におけるトラスツズマブデルクステカン投与例の検討, 第32回日本乳癌学会学術総会, Jul. 2024.
25.	細川暉雄, Hiroaki Inoue, Tomohiro Inui, Sawaka Yukishige, Souichiro Sasa, Mariko Aoyama, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : ペムブロリズマブ投与中に下垂体機能低下を認めたトリプルネガティブ乳癌の1例, 第32回日本乳癌学会学術総会, Jul. 2024.
26.	Souichiro Sasa, Hiroaki Inoue, Sawaka Yukishige, Tomohiro Inui, Mariko Aoyama, 細川暉雄, Atsushi Morishita, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当院における周術期トリプルネガティブ乳癌に対するペムブロリズマブの使用経験, 第32回日本乳癌学会学術総会, Jul. 2024.
27.	Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, Sawaka Yukishige, Naoki Miyamoto, Atsushi Morishita, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : CDK4/6阻害剤における有害事象とCARGスコアについての検討, 第32回日本乳癌学会学術総会, Jul. 2024.
28.	Sawaka Yukishige, Hiroaki Inoue, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : エリブリン投与中の病勢進行形式と末梢血総リンパ球数の関係について, 第32回日本乳癌学会学術総会, Jul. 2024.
29.	細川暉雄, Seiya Inoue, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Mariko Aoyama, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後に急激な経過を辿った緑膿菌肺炎の1例, 第78回日本食道学会学術集会, Jul. 2024.
30.	遠藤鋭人, Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後の自己免疫性膵炎の1切除例, 第78回日本食道学会学術集会, Jul. 2024.
31.	Satoshi Fujiwara, 髙杉遥, Seiya Inoue, Masakazu Goto, 細川暉雄, Taihei Takeuchi, Hiroyuki Sumitomo, Atsushi Morishita, Hiroaki Toba and Hiromitsu Takizawa : 根治的食道亜全摘術後の再発症例の検討, 第78回日本食道学会学術集会, Jul. 2024.
32.	Masakazu Goto, Seiya Inoue, 細川暉雄, 髙杉遥, Atsushi Morishita, Satoshi Fujiwara, Hiroaki Toba and Hiromitsu Takizawa : 切除可能食道癌における化学療法後のWatch and Wait戦略は治療選択肢となりえるか?, 第78回日本食道学会学術集会, Jul. 2024.
33.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 吻合部トラブル回避のわれわれの工夫∼吻合法の比較検討∼, 第78回日本食道学会学術集会, Jul. 2024.
34.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 吻合トラブル回避を目指した食道胃管吻合法の検討, 第67回関西胸部外科学会学術集会, Jun. 2024.
35.	Hiroaki Inoue, Sawaka Yukishige, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Hiroyuki Morino, 吉田友紀子, 宮本容子, Yoshie Imai, Masakazu Goto and Hiromitsu Takizawa : 当院乳癌患者におけるBRCA遺伝学的検査の現状, 第30回日本遺伝性腫瘍学会学術集会, May 2024.
36.	細川暉雄, Mariko Aoyama, Taihei Takeuchi, Tomohiro Inui, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : レンバチニブ投与により間質性肺炎をきたした甲状腺低分化癌多発骨転移の1例, 第36回日本内分泌外科学会総会, May 2024.
37.	Shin-ichi Sakamoto, Mariko Aoyama, 細川暉雄, Taihei Takeuchi, 髙杉遥, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba, Yoshimi Bando, Hisanori Uehara and Hiromitsu Takizawa : 穿刺吸引細胞への免疫染色が診断に有用であった甲状腺原発悪性リンパ腫の2例, 第36回日本内分泌外科学会総会, May 2024.
38.	Mariko Aoyama, Seiya Inoue, 細川暉雄, Taihei Takeuchi, 髙杉遥, Shin-ichi Sakamoto, Naoki Miyamoto, Atsushi Morishita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 縦隔内甲状腺・副甲状腺腫瘍に対する縦隔鏡手術のCadaver surgical trainingについて, 第36回日本内分泌外科学会総会, May 2024.
39.	Masakazu Goto, Seiya Inoue, 細川暉雄, 髙杉遥, Atsushi Morishita, Satoshi Fujiwara, Hiroaki Toba and Hiromitsu Takizawa : 切除不能進行・再発食道癌に対するICIを組み入れた治療戦略の安全性と有効性について, 第110回日本消化器病学会総会, May 2024.
40.	Masakazu Goto, Seiya Inoue, 細川暉雄, 髙杉遥, Atsushi Morishita, Satoshi Fujiwara, Hiroaki Toba and Hiromitsu Takizawa : 当科における食道癌に対するICI投与の現状について∼術後補助と切除不能・再発症例における安全性と治療効果について∼, 第124回日本外科学会定期学術集会, Apr. 2024.
41.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba and Hiromitsu Takizawa : 地方大学において外科医不足を補うために∼特定看護師の役割∼, 第124回日本外科学会定期学術集会, Apr. 2024.
42.	Mariko Aoyama, Seiya Inoue, 細川暉雄, Taihei Takeuchi, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 縦隔内甲状腺・副甲状腺腫瘍に対する縦隔鏡手術の有用性, 第124回日本外科学会定期学術集会, Apr. 2024.
43.	Masakazu Goto, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Satoshi Fujiwara, Seiya Inoue and Hiroaki Toba : 当院における腹臥位胸腔鏡下食道亜全摘術の術後短期成績について∼上縦隔リンパ節郭清における有用性∼, 第36回日本内視鏡外科学会総会, Dec. 2023.
44.	Satoshi Fujiwara, 竹内大平, 髙杉遥, Hiroyuki Sumitomo, Seiya Inoue, Masakazu Goto and Hiroaki Toba : 腹腔鏡下胃管作成における手術時間短縮に向けての取り組み, 第36回日本内視鏡外科学会総会, Dec. 2023.
45.	杉本花奈乃, Hiroaki Inoue, Souichiro Sasa, Tomohiro Inui, 行重佐和香, Mariko Aoyama, Hiroaki Toba, Masakazu Goto, Yoshimi Bando and Hiromitsu Takizawa : 乳頭の硬結で発見された浸潤性小葉癌の1例, 第33回日本乳癌検診学会学術総会, Nov. 2023.
46.	行重佐和香, Hiroaki Inoue, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Takeshi Oya, Yoshimi Bando, Masakazu Goto and Hiromitsu Takizawa : 乳腺原発神経内分泌腫瘍の1例, 第33回日本乳癌検診学会学術総会, Nov. 2023.
47.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川喗雄, 竹内大平, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Atsushi Morishita, 三崎万理子, Naoya Kawakita, 鳥羽博明, Hiromitsu Takizawa and Koichi Tomita : 縦隔鏡下食道切除術を安全に行うトレーニング, 第85回日本臨床外科学会総会, Nov. 2023.
48.	細川暉雄, Mariko Aoyama, 竹内大平, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : Dynamic CTにより残存腺腫を同定した原発性副甲状腺機能亢進症の1例, 第85回日本臨床外科学会総会, Nov. 2023.
49.	Mariko Aoyama, 細川暉雄, 竹内大平, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当科における中リスク甲状腺乳頭癌における治療成績に関する検討, 第85回日本臨床外科学会総会, Nov. 2023.
50.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, 竹内大平, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Atsushi Morishita, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa and Yoshihiro Tsuruo : 縦隔鏡下食道切除術を安全に行うためのトレーニング, 第85回日本臨床外科学会総会, Nov. 2023.
51.	阿部祐也, Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, 行重佐和香, Kazumasa Okumura, Naoki Miyamoto, Masakazu Goto, Hiroaki Toba, Takashi Kawanaka and Hiromitsu Takizawa : 顔面のしびれを契機に発見された頭蓋底骨転移に対し放射線治療が有効であった1例, 第20回日本乳癌学会中国四国地方会, Sep. 2023.
52.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 細川暉雄, Taihei Takeuchi, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba and Hiromitsu Takizawa : ICG胃管血流評価を意識した食道胃管吻合の取り組み, 日本蛍光ガイド手術研究会第6回学術集会, Sep. 2023.
53.	Sawaka Yukishige, Hiroaki Inoue, Tomohiro Inui, Naoki Miyamoto, Souichiro Sasa, Mariko Aoyama, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 高Ca血症のコントロールに難渋した乳癌多発骨転移の1例, 第98回中国四国外科学会総会/第28回中国四国内視鏡外科研究会, Aug. 2023.
54.	Naoki Miyamoto, Mariko Aoyama, 井﨑富由実, Taihei Takeuchi, Hiroyuki Sumitomo, Shin-ichi Sakamoto, Seiya Inoue, Satoshi Fujiwara, Naoya Kawakita, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : レンバチニブ投与により難治性気胸を発症した甲状腺未分化癌の一例, 第98回中国四国外科学会総会/第28回中国四国内視鏡外科研究会, Aug. 2023.
55.	Satoshi Fujiwara, Sawaka Yukishige, Taihei Takeuchi, 髙杉遥, Hiroyuki Sumitomo, Atsushi Morishita, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 食道癌手術における胃管作成に対する術式の検討, 第98回中国四国外科学会総会/第28回中国四国内視鏡外科研究会, Aug. 2023.
56.	Hiroaki Inoue, Souichiro Sasa, Mariko Aoyama, Tomohiro Inui, Sawaka Yukishige, Naoki Miyamoto, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : 高齢乳癌患者におけるCDK4/6阻害剤投与の検討, 第98回中国四国外科学会総会/第28回中国四国内視鏡外科研究会, Aug. 2023.
57.	Mariko Aoyama, 細川暉雄, Taihei Takeuchi, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当科における進行・再発甲状腺癌に対するレンバチニブの使用経験と今後の治療戦略, 第98回中国四国外科学会総会/第28回中国四国内視鏡外科研究会, Aug. 2023.
58.	Masakazu Goto, 井﨑富由実, Sawaka Yukishige, Taihei Takeuchi, Hiroyuki Sumitomo, Satoshi Fujiwara, Seiya Inoue and Hiromitsu Takizawa : 当科における高齢者食道癌患者に対する治療戦略と予後について, 第78回日本消化器外科学会総会, Jul. 2023.
59.	Satoshi Fujiwara, 井﨑富由実, Taihei Takeuchi, Hiroyuki Sumitomo, Seiya Inoue, Masakazu Goto and Hiromitsu Takizawa : 食道癌手術における胃管作成に対する術式の検討, 第77回日本食道学会学術集会, Jun. 2023.
60.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 井﨑富由実, Taihei Takeuchi, Hiroyuki Sumitomo, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : NAC後の術後補助化学療法の有用性の検討, 第77回日本食道学会学術集会, Jun. 2023.
61.	Masakazu Goto, 井﨑富由実, Sawaka Yukishige, Taihei Takeuchi, Hiroyuki Sumitomo, Mariko Aoyama, Satoshi Fujiwara, Seiya Inoue, Hiroaki Toba and Hiromitsu Takizawa : 当院における高齢者食道癌患者に対する治療と予後について, 第77回日本食道学会学術集会, Jun. 2023.
62.	Sawaka Yukishige, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Hiroaki Inoue, Kazumasa Okumura, Masakazu Goto, Hiroaki Toba, Hiromitsu Takizawa, 甫喜本憲弘 and 頼田顕辞 : 局所皮弁による再建を行った腋窩副乳癌の1例, 第31回日本乳癌学会学術総会, Jun. 2023.
63.	Mariko Aoyama, Hiroaki Inoue, Tomohiro Inui, Souichiro Sasa, Kazumasa Okumura, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : トリプルネガティブ乳癌におけるHER2低発現の有無による臨床病理学的所見と予後の検討, 第31回日本乳癌学会学術総会, Jun. 2023.
64.	Shin-ichi Sakamoto, Mariko Aoyama, 井﨑富由実, Taihei Takeuchi, Hiroyuki Sumitomo, Naoki Miyamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : レンバチニブ投与により難治性気胸を発症した甲状腺未分化癌の一例, 第35回日本内分泌外科学会総会, Jun. 2023.
65.	井﨑富由実, Mariko Aoyama, Taihei Takeuchi, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 排便時の怒責が誘因となった甲状腺被膜出血の1例, 第35回日本内分泌外科学会総会, Jun. 2023.
66.	Mariko Aoyama, 井﨑富由実, Tomohiro Inui, Shin-ichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : VANS甲状腺悪性腫瘍手術の手術成績, 第35回日本内分泌外科学会総会, Jun. 2023.
67.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 井﨑富由実, Taihei Takeuchi, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Mariko Aoyama, Mika Takashima, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa and Yoshihiro Tsuruo : 縦隔鏡下食道切除術における開胸手技習得のわれわれの取り組み, 第123回日本外科学会定期学術集会, Apr. 2023.
68.	Hiroyuki Sumitomo, Hiroaki Toba, 井﨑富由実, Taihei Takeuchi, Tomohiro Inui, Shin-ichi Sakamoto, Naoki Miyamoto, Souichiro Sasa, Mariko Aoyama, Hiroaki Inoue, Mika Takashima, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Kazumasa Okumura, Yukikiyo Kawakami and Hiromitsu Takizawa : 大きな縦隔腫瘍に対する気縦隔を用いた縦隔鏡アプローチの有用性, 第123回日本外科学会定期学術集会, Apr. 2023.
69.	井﨑富由実, Mariko Aoyama, 竹内大平, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 抗血栓薬内服中に甲状腺被膜出血をきたし緊急手術を要した1例, 第51回中国四国甲状腺外科研究会, Feb. 2023.
70.	Shin-ichi Sakamoto, Mariko Aoyama, Tomohiro Inui, Naoki Miyamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : Weekly paclitaxelと放射線外照射を併用した甲状腺未分化癌の一例, 第51回中国四国甲状腺外科研究会, Feb. 2023.
71.	Mariko Aoyama, 井﨑富由実, 竹内大平, Shin-ichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 分子標的治療薬の手術前使用の経験, 第51回中国四国甲状腺外科研究会, Feb. 2023.
72.	HAYAMI Yuna, Sonoko Yasui-Yamada, NAKAMURA Nayu, Miyu Kubo, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto and Yasuhiro Hamada : 食道癌周術期の体重減少に関わる因子の検討, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
73.	Satoshi Fujiwara, 竹内大平, Hiroyuki Sumitomo, Seiya Inoue and Masakazu Goto : 食道癌手術における腹腔鏡下胃管作成術の検討, 第35回日本内視鏡外科学会総会, Dec. 2022.
74.	Masakazu Goto, 竹内大平, Hiroyuki Sumitomo, Satoshi Fujiwara and Seiya Inoue : 胸腔鏡下食道亜全摘術における胸部操作時間の短縮に向けた取り組み, 第35回日本内視鏡外科学会総会, Dec. 2022.
75.	竹内大平, Masakazu Goto, 井﨑富由実, 住友弘幸, Seiya Inoue, Satoshi Fujiwara and Hiromitsu Takizawa : 遠隔期再発を来した食道癌の1例より術後サーベイランスについて考える, 第84回日本臨床外科学会総会, Nov. 2022.
76.	Masakazu Goto, 井﨑富由実, 竹内大平, Hiroyuki Sumitomo, Satoshi Fujiwara, Seiya Inoue and Hiromitsu Takizawa : 術前化学療法によりpCRが得られた食道癌24例の検討とその後の転帰について, 第33回日本消化器癌発生学会総会, Nov. 2022.
77.	Souichiro Sasa, Hiroaki Inoue, INUI Tomohiro, Naoki Miyamoto, Mariko Aoyama, Kazumasa Okumura, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 原因不明の発熱により治療方針決定に難渋した局所進行乳癌の一例, 第32回日本乳癌検診学会学術総会, Nov. 2022.
78.	Souichiro Sasa, Hiroaki Inoue, Tomohiro Inui, Mariko Aoyama, Kazumasa Okumura, 板東真由, Ichiro Hashimoto, Atsuko Yoshida, 山口美代子, Hiroaki Toba, Masakazu Goto and Hiromitsu Takizawa : 多診療科・多職種チーム連携が有用であった妊娠期乳癌の1例, 第10回日本乳房オンコプラスティックサージャリー学会総会, Oct. 2022.
79.	Hiroaki Toba, Hiroaki Inoue, Mika Takashima, Seiya Inoue, Naoya Kawakita, Masakazu Goto and Hiromitsu Takizawa : より良いがんの地域連携体制構築のための包括的な取り組み, 第60回日本癌治療学会学術集会, Oct. 2022.
80.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, Takahiro Yoshida, Akira Tangoku, 竹内大平, 住友弘幸, Naoki Miyamoto, Shin-ichi Sakamoto, Mika Takashima, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa and 鶴尾吉保 : 縦隔鏡下食道切除術を安全に行うためのわれわれのトレーニング, 第75回日本胸部外科学会定期学術集会, Oct. 2022.
81.	Masakazu Goto, Satoshi Fujiwara, Seiya Inoue, Takahiro Yoshida and Hiromitsu Takizawa : 腹臥位食道亜全摘術導入後の胸部操作時間のラーニングカーブについて, 第76回日本食道学会学術集会, Sep. 2022.
82.	Satoshi Fujiwara, Takahiro Yoshida, Masakazu Goto, Seiya Inoue, INUI Tomohiro, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 同時性肺腫瘍を伴う進行食道癌に対し，一期的手術を施行した3例の検討, 第76回日本食道学会学術集会, Sep. 2022.
83.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, INUI Tomohiro, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道切除後の最適な胃管再建法, 第76回日本食道学会学術集会, Sep. 2022.
84.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, Hiroyuki Sumitomo, 井﨑富由実, 竹内大平, Tomohiro Inui, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道胃管吻合におけるわれわれの取り組み, 第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
85.	Hiroaki Inoue, INUI Tomohiro, Souichiro Sasa, Mariko Aoyama, Kazumasa Okumura, Naoki Miyamoto, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 骨髄癌症，硬膜下血腫によりoncological emergencyの状態であったが救命し得た乳癌多発骨転移の1例, 第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
86.	Mariko Aoyama, Shin-ichi Sakamoto, INUI Tomohiro, Naoki Miyamoto, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : Weekly pacltaxelと放射線外照射が有効であった甲状腺未分化癌の1例, 第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
87.	Takeshi Nishino, Takahiro Yoshida, 湯浅康弘, 西岡康平, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto and Akira Tangoku : 縦隔鏡と胸腔鏡各々のメリットを生かしたハイブリッド食道癌根治術, 第77回日本消化器外科学会総会, Jul. 2022.
88.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, INUI Tomohiro, Shin-ichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道切除後再建術における取り組み-ICG血流評価法とCollard変法の有用性-, 第77回日本消化器外科学会総会, Jul. 2022.
89.	Mariko Aoyama, INUI Tomohiro, Shin-ichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 肺転移と腎転移をきたした甲状腺乳頭癌の1症例, 第34回日本内分泌外科学会総会(ハイブリッド開催), Jun. 2022.
90.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa, 橋本脩平 and Yasuhiro Hamada : 食道癌根治術における術前GLIM criteriaを用いた術後成績の予測, 第122回日本外科学会定期学術集会(ハイブリッド開催), Apr. 2022.
91.	Satoshi Fujiwara, Takahiro Yoshida, Takeshi Nishino, Hiroaki Toba, Seiya Inoue, Masakazu Goto, Naoya Kawakita and Hiromitsu Takizawa : 超音波気管支鏡による進行食道癌の壁深達度診断と治療戦略, 第74回日本胸部外科学会定期学術集会, Oct. 2021.
92.	Hidenori Maki, Seiya Inoue, 南城和正, Mariko Aoyama, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida, Hiromitsu Takizawa and Akira Tangoku : 巨大食道裂孔ヘルニアを伴う特発性食道破裂の一例, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
93.	南城和正, Seiya Inoue, Hidenori Maki, 庄野隆志, Mariko Aoyama, Takeshi Nishino, Masakazu Goto, Takahiro Yoshida, Hiromitsu Takizawa and Akira Tangoku : 食道癌術後に門脈ガス血症・腸管気腫症を発症した1例, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
94.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 食道癌に対する縦隔鏡・胸腔鏡併用による合理的な縦隔リンパ節郭清, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
95.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto and Akira Tangoku : 食道胃接合部癌におけるリンパ流の検討, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
96.	Masakazu Goto, Seiya Inoue, Takeshi Nishino, Takahiro Yoshida and Akira Tangoku : The investigation of anastomotic stricture after esophagectomy, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
97.	庄野隆志, Seiya Inoue, 南城和正, Yasuyo Saijo, Hidenori Maki, Mariko Aoyama, Takeshi Nishino, Masakazu Goto, Takahiro Yoshida, Hiromitsu Takizawa and Akira Tangoku : 術前化学療法に効果を示し，根治手術を施行した進行食道粘表皮癌の1例, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
98.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, 庄野隆志, 南城和正, Hidenori Maki, Mariko Aoyama, Akira Tangoku, 橋本脩平 and Yasuhiro Hamada : 当院の食道癌集学的チーム医療の現状と栄養評価, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
99.	Takahiro Yoshida, Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, Hiromitsu Takizawa, Akira Tangoku and Takeshi Nishino : 反回神経麻痺回避のための左頸部アポローチによる縦隔鏡下左反回神経周囲リンパ節郭清の工夫, 第96回中国四国外科学会総会・第26回中国四国内視鏡外科研究会, Sep. 2021.
100.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 術前化学療法時からの専門的口腔機能管理が食道癌術後の長期予後を改善する, 第46回日本外科系連合学会学術集会(Web開催), Jun. 2021.
101.	Masakazu Goto, Seiya Inoue, Takeshi Nishino, Takahiro Yoshida and Akira Tangoku : The difference of expression of chemokines and their receptors in esophageal cancer, 第64回関西胸部外科学会学術集会(Web開催), Jun. 2021.
102.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 頸・腹同時進行による縦隔鏡下食道切除術の工夫-われわれのこだわり-, 第121回日本外科学会定期学術集会, Apr. 2021.
103.	Takahiro Yoshida, Akira Tangoku, Takeshi Nishino, Seiya Inoue and Masakazu Goto : 食道胃接合部表在癌に対する術前CTリンパ管造影による郭清範囲決定, 第121回日本外科学会定期学術集会, Apr. 2021.
104.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Kai Mizobuchi, 竹原恵美, Mariko Aoyama, Masami Morimoto and Akira Tangoku : 当科における縦隔鏡下食道切除術の安全性に関する検討, 第33回日本内視鏡外科学会総会(ハイブリッド開催), Mar. 2021.
105.	Hiroaki Toba, Takahiro Yoshida, Mika Takashima, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Jun-ichi Seike and Akira Tangoku : かかりつけ医と連携してより良い食道癌診療をするための包括的な取り組み, 第74回日本食道学会学術集会(ハイブリッド型開催), Dec. 2020.
106.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Kai Mizobuchi, 鈴木恵美, Mariko Aoyama, Masami Morimoto and Akira Tangoku : 縫合不全回避のためのわれわれの工夫, 第74回日本食道学会学術集会(ハイブリッド型開催), Dec. 2020.
107.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Akira Tangoku : 切除可能胸部食道癌に対する術前DTX+5-FU+CDDP療法の個別治療と組織学的評価の意義, 第74回日本食道学会学術集会(ハイブリッド型開催), Dec. 2020.
108.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 食道癌手術における縦隔鏡アプローチの進歩と現状, 第74回日本食道学会学術集会(ハイブリッド型開催), Dec. 2020.
109.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Mariko Aoyama, Naoya Kawakita, Hiromitsu Takizawa and Akira Tangoku : 生検組織を用いた食道扁平上皮癌に対する初回化学療法の効果と予後予測因子の解明, 第73回日本胸部外科学会定期学術集会(Web開催), Oct. 2020.
110.	山本清成, Takeshi Nishino, 庄野隆志, 南城和正, Hidenori Maki, Mika Takashima, Daisuke Matsumoto, Naoya Kawakita, Seiya Inoue, Masakazu Goto, Takahiro Yoshida, Hiroaki Toba, Mitsuteru Yoshida, Hiromitsu Takizawa and Akira Tangoku : 気管分岐部狭窄を伴う気管支瘻形成進行食道癌に対する集学的治療の経験, 第73回日本胸部外科学会定期学術集会(Web開催), Oct. 2020.
111.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 根治性と合併症軽減の両立を目指した縦隔鏡下リンパ節郭清手技, 第73回日本胸部外科学会定期学術集会(Web開催), Oct. 2020.
112.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto, Akira Tangoku, Yoshihiro Tsuruo, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道外科手術におけるカダバートレーニングの経験と展望, 第73回日本胸部外科学会定期学術集会(Web開催), Oct. 2020.
113.	庄野隆志, Takeshi Nishino, 南城和正, 山本清成, 牧秀則, INUI Tomohiro, Soichiroh Sasa, Mariko Aoyama, Hiroaki Inoue, Seiya Inoue, Masakazu Goto, Kazumasa Okumura, Takahiro Yoshida and Akira Tangoku : 乳癌術後20年目に食道転移をきたした1例, 第82回日本臨床外科学会総会, Oct. 2020.
114.	Takeshi Nishino, Takahiro Yoshida, 庄野隆志, 南城和正, 牧秀則, 山本清成, Seiya Inoue, Masakazu Goto and Akira Tangoku : 縦隔鏡下食道癌根治術における縦隔リンパ節郭清の工夫, 第82回日本臨床外科学会総会, Oct. 2020.
115.	Masakazu Goto and Liu Mingyao : Chemokines and their receptors as biomarkers in esophageal cancer, 第120回日本外科学会定期学術集会(Web開催), Aug. 2020.
116.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Akira Tangoku : 術前CTリンパ管造影により得られる食道胃接合部癌に対する至適リンパ節郭清, 第120回日本外科学会定期学術集会(Web開催), Aug. 2020.
117.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue and Akira Tangoku : 食道切除術後の心房細動に対する予防的ランジオロール投与の効果, 第63回関西胸部外科学会学術集会(Web開催), Aug. 2020.
118.	Takeshi Nishino, Seiya Inoue, Masakazu Goto, Takahiro Yoshida and Akira Tangoku : 根治を目指した縦隔鏡下食道切除術:縦隔リンパ節郭清の工夫と定型化, 第32回日本内視鏡外科学会総会, Dec. 2019.
119.	Yoshihito Furukita, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Takeshi Nishino and Akira Tangoku : 食道癌における腫瘍内リンパ球浸潤は化学療法の治療効果を予見する?, 第32回日本バイオセラピィ学会学術集会総会, Nov. 2019.
120.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto, Kai Mizobuchi, 竹原恵美 and Akira Tangoku : 当院における下咽頭癌に対する他科連携手術, 第81回日本臨床外科学会総会, Nov. 2019.
121.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Kai Mizobuchi, 竹原恵美, 青山万理子, Soichiroh Sasa, 井上寛章, Masami Morimoto, Miyuki Kanematsu, Mitsuhiro Tsuboi, Hirokazu Takechi and Akira Tangoku : 食道癌術後における大建中湯投与の有効性-術後早期から晩期までの効果-, 第81回日本臨床外科学会総会, Nov. 2019.
122.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto, Mika Takashima, Hiroaki Toba, Hiromitsu Takizawa and Akira Tangoku : 《パネルディスカッション》隣接臓器浸潤を伴う局所進行食道癌に対する集学的治療Oncological Emergencyへの対応と食道バイパス手術併用によるQOLの評価, 第72回日本胸部外科学会定期学術集会, Oct. 2019.
123.	Takeshi Nishino, Seiya Inoue, Masakazu Goto, Takahiro Yoshida and Akira Tangoku : 《ビデオシンポジウム》縦隔鏡下食道癌根治術における最適な縦隔リンパ節郭清とは, 第72回日本胸部外科学会定期学術集会, Oct. 2019.
124.	Takeshi Nishino, Seiya Inoue, Masakazu Goto, Takahiro Yoshida and Akira Tangoku : 食道癌の気管・気管支浸潤の診断における超音波気管支鏡の有用性, 第57回日本癌治療学会学術集会, Oct. 2019.
125.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Kai Mizobuchi, Masakazu Goto and Akira Tangoku : 75歳以上胸部食道癌における手術治療に関する検討, 第94回中国四国外科学会総会・第24回中国四国内視鏡外科研究会, Sep. 2019.
126.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Kai Mizobuchi, 竹原恵美, Naoki Miyamoto and Masakazu Goto : T4食道癌に対する治療戦略-放射線療法を温存したDocetaxel/5-FU/CDDPによるinduction chemotherapyの有効性, 第94回中国四国外科学会総会・第24回中国四国内視鏡外科研究会, Sep. 2019.
127.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Akira Tangoku : Strategies based on the efficacy of preoperative DCF in cStage II,III thoracic esophageal cancer, 第74回日本消化器外科学会総会, Jul. 2019.
128.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Akira Tangoku : 食道胃接合部癌におけるCTリンパ管造影を用いた至適リンパ節郭清, 第62回関西胸部外科学会学術集会, Jun. 2019.
129.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 縦隔鏡下食道癌根治術における縦隔リンパ節郭清の工夫-縦隔鏡操作と経裂孔操作の連携-, 第62回関西胸部外科学会学術集会, Jun. 2019.
130.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto and Akira Tangoku : 《口演1》食道胃接合部癌における原発巣からのリンパルートと至適リンパ節郭清, 第73回日本食道学会学術集会, Jun. 2019.
131.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 《ワークショップ》超音波気管支鏡による食道癌の気管・気管支浸潤の診断法についての研究, 第73回日本食道学会学術集会, Jun. 2019.
132.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 縦隔鏡下食道癌根治術における縦隔鏡操作と経裂孔操作の連携による縦隔リンパ節郭清の工夫, 第73回手術手技研究会, May 2019.
133.	Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, Masakazu Goto, Mitsuhiro Tsuboi, Mariko Aoyama, Hiroaki Toba, Mitsuteru Yoshida, Hiromitsu Takizawa, Akira Tangoku, Hiro-omi Kanayama and Yoshihiro Tsuruo : 《CST推進委員会・厚生労働班会議合同企画》未固定カダバーによる教育と研究徳島大学の取り組み, 第119回日本外科学会定期学術集会, Apr. 2019.
134.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, 鈴木恵美, Ryo Yamada, Soichiroh Sasa, Mariko Aoyama, Masami Morimoto, Miyuki Kanematsu, Masakazu Goto, Hirokazu Takechi, Akira Tangoku, Ayami Kashiji and Yasuhiro Hamada : 《ワークショップ》当院における多職種介入による食道癌集学的治療のアウトカム, 第119回日本外科学会定期学術集会, Apr. 2019.
135.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Miyuki Kanematsu, Masakazu Goto, 鈴木恵美, 山田亮, Soichiroh Sasa, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 《シンポジウム》気管浸潤を伴う進行食道癌に対する治療戦略-R0手術を達成するための術前診断と手術手技の工夫-, 第119回日本外科学会定期学術集会, Apr. 2019.
136.	Takeshi Nishino, Takahiro Yoshida, 鈴木恵美, 山田亮, Soichiroh Sasa, Miyuki Kanematsu, Seiya Inoue, Masakazu Goto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 縦隔鏡下食道癌根治術を安全に導入するために∼ラーニングステップとしての縦隔鏡・胸腔鏡ハイブリッド手術∼, 第80回日本臨床外科学会総会, Nov. 2018.
137.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, 鈴木恵美, 山田亮, Mariko Aoyama, Mayumi Ikeuchi, Soichiroh Sasa, Masami Morimoto, Miyuki Kanematsu, Mitsuhiro Tsuboi, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 《スポンサードシンポジウム:ワークショップ》食道癌術後の栄養および消化管機能回復への大建中湯の可能性, 第80回日本臨床外科学会総会, Nov. 2018.
138.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 《シンポジウム》縦隔鏡下食道癌根治術を目指した縦隔鏡・胸腔鏡ハイブリッド食道切除術, 第71回日本胸部外科学会定期学術集会, Oct. 2018.
139.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Akira Tangoku and Yasuhiro Hamada : 食道癌周術期管理における新たな取り組み, 第73回日本消化器外科学会総会, Jul. 2018.
140.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 縦隔鏡下食道癌根治術を目指した縦隔鏡・胸腔鏡ハイブリッド手術, 第73回日本消化器外科学会総会, Jul. 2018.
141.	Takahiro Yoshida, Akira Tangoku, Takeshi Nishino, Masakazu Goto and Seiya Inoue : Novel diagnostic approach for lymph node metastasis using CT lymphography in cT1 esophageal cancer, 第73回日本消化器外科学会総会, Jul. 2018.
142.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : T4食道癌に対するコンバージョン手術の成績と展望, 第72回日本食道学会学術集会, Jun. 2018.
143.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 縦隔鏡下食道癌根治術を目指したラーニングステップとしての縦隔鏡・胸腔鏡hybrid手術, 第72回日本食道学会学術集会, Jun. 2018.
144.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, 行重佐和香, Kazumasa Okumura, Hirokazu Takechi and Akira Tangoku : HER2およびEGFRの発現から見た食道癌の治療戦略(第二報), 第72回日本食道学会学術集会, Jun. 2018.
145.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Hirokazu Takechi and Akira Tangoku : 《ワークショップ》食道癌に対する術前化学療法を中心とした集学的治療の効果と標準化に向けた課題, 第72回日本食道学会学術集会, Jun. 2018.
146.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Hirokazu Takechi and Akira Tangoku : 《一般口演》当科における縦隔鏡下食道切除術の取り組み, 第61回関西胸部外科学会学術集会, Jun. 2018.
147.	Naoya Kawakita, Hiromitsu Takizawa, Takahiro Yoshida, Toru Sawada, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Mitsuhiro Tsuboi, Hiroaki Toba, Yukikiyo Kawakami, Mitsuteru Yoshida, Kazuya Kondo and Akira Tangoku : 《Case Presentation Award》有茎大網弁被覆により有瘻性膿胸を回避できた右上葉管状肺葉切除の1例, 第61回関西胸部外科学会学術集会, Jun. 2018.
148.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Jun-ichi Seike and Akira Tangoku : 《ビデオシンポジウム》縦隔鏡下食道癌根治術を目指したlearning stepとしての縦隔鏡・胸腔鏡hybrid手術, 第43回日本外科系連合学会学術集会, Jun. 2018.
149.	Hiromitsu Takizawa, Naoya Kawakita, Mitsuteru Yoshida, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida, Toru Sawada, Mitsuhiro Tsuboi, Hiroaki Toba, Yukikiyo Kawakami, Kazuya Kondo and Akira Tangoku : 《シンポジウム》未固体遺体による高難度手術の術前シミュレーション, 第41回日本呼吸器内視鏡学会学術集会, May 2018.
150.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto and Akira Tangoku : 縦隔鏡下食道癌根治術を目指したラーニングステップとしての縦隔鏡・胸腔鏡ハイブリッド手術, 第72回手術手技研究会, May 2018.
151.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Kazumasa Okumura, 行重佐和香, Hiroaki Toba and Akira Tangoku : T4食道癌に対する集学的治療と課題, 第118回日本外科学会定期学術集会, Apr. 2018.
152.	Hirokazu Takechi, 松岡由江, 一宮由貴, 三木幸代, 青山万理子, 池内真由美, 森本雅美, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Misako Nakagawa, Kazumasa Okumura, Hiroaki Toba, Takahiro Yoshida and Akira Tangoku : 緩和ケア認定看護師介入により治療満足度が高まった局所進行乳腺小葉癌の1例, 第55回日本癌治療学会学術集会, Oct. 2017.
153.	Hirokazu Takechi, 行重佐和香, 青山万理子, 池内真由美, 森本雅美, Seiya Inoue, Masakazu Goto, Takeshi Nishino, Misako Nakagawa, Kazumasa Okumura, Hiroaki Toba, Takahiro Yoshida and Akira Tangoku : 乳癌治療における近藤誠理論の問題点を実感した1例, 第14回日本乳癌学会中国四国地方会, Sep. 2017.
154.	Masakazu Goto, 仁木俊助, Naoya Kawakita and Yukikiyo Kawakami : 鼠径ヘルニア修復術9年後にメッシュプラグ感染をきたした2例, 第72回日本消化器外科学会総会, Jul. 2017.
155.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Jun-ichi Seike and Akira Tangoku : 食道癌治療における大建中湯，六君子湯の効果についての臨床研究, 第72回日本消化器外科学会総会, Jul. 2017.
156.	Masakazu Goto, 仁木俊助, Naoya Kawakita and Yukikiyo Kawakami : 鼠径ヘルニア修復術から9年後にメッシュプラグ感染をきたした1例, 第42回日本外科系連合学会学術集会, Jun. 2017.
157.	Takahiro Yoshida, Yoshihito Furukita, 西野豪志, Hirokazu Takechi, 森下敦司, 池田真由美, 森本雅美, 湊拓也, Masakazu Goto, Yota Yamamoto, Takanori Miyoshi and Akira Tangoku : 胸部食道癌に対する集学的治療として食道バイパス術を行った3例, 第88回中国四国外科学会総会, Sep. 2013.
158.	Masakazu Goto, Akira Tangoku, 池田真由美, 古川尊子, 西野豪志, Koichiro Kajiura, Yoshihito Furukita, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 当科における食道癌術後吻合部狭窄症例の検討, 第68回日本消化器外科学会総会, Jul. 2013.
159.	Yoshihito Furukita, 湊拓也, Akira Tangoku, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌術後合併症の軽減を目指した術前リスク評価と術式選択, 第68回日本消化器外科学会総会, Jul. 2013.
160.	西野豪志, Akira Tangoku, 池田真由美, 古川尊子, Masakazu Goto, Yota Yamamoto, Yoshihito Furukita, Koichiro Kajiura, Hirokazu Takechi and Jun-ichi Seike : 食道扁平上皮癌に対する術前DFP療法(weekly DOC+low-dose FP)の有効性, 第68回日本消化器外科学会総会, Jul. 2013.
161.	Yota Yamamoto, 池田真由美, 古川尊子, 西野豪志, Masakazu Goto, Yoshihito Furukita, Koichiro Kajiura, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 食道癌周術期における大建中湯投与の有用性の検討, 第68回日本消化器外科学会総会, Jul. 2013.
162.	西野豪志, Yota Yamamoto, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 《シンポジウム》食道扁平上皮癌に対する術前DFP療法(weekly DOC+low-dose FP)の有効性, 第56回関西胸部外科学会学術集会, Jun. 2013.
163.	Yoshihito Furukita, 湊拓也, Akira Tangoku, 坂本晋一, 宮本佳美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 《シンポジウム》食道癌術後合併症の軽減を目指した術前リスク評価と術式選択, 第56回関西胸部外科学会学術集会, Jun. 2013.
164.	Yoshihito Furukita, Akira Tangoku, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌化学療法におけるEPA強化栄養剤(プロシュア®)導入効果, 第67回日本食道学会学術集会, Jun. 2013.
165.	Yota Yamamoto, 西野豪志, Masakazu Goto, Yoshihito Furukita, 湯浅康弘, 山井礼道, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道亜全摘術後の長期的体重変化の検討, 第67回日本食道学会学術集会, Jun. 2013.
166.	Masakazu Goto, 西野豪志, 湊拓也, Yoshihito Furukita, Yota Yamamoto, 湯浅康弘, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道切除・胃管再建術後の吻合部狭窄症例の検討, Jun. 2013.
167.	河北直也, Yoshihito Furukita, Akira Tangoku, 池田真由美, 古川尊子, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : Niti-STM食道ステントロングカバータイプが有用であった下部食道癌の1例, 第67回日本食道学会学術集会, Jun. 2013.
168.	西野豪志, Yota Yamamoto, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道扁平上皮癌に対する術前DFP療法(weekly DOC+low-dose FP)の有効性, 第67回日本食道学会学術集会, Jun. 2013.
169.	Yota Yamamoto, 坂本晋一, 西野豪志, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道癌治療におけるHER-family蛋白発現と治療効果・予後との関連の検討, 第38回日本外科系連合学会学術集会, Jun. 2013.
170.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 宮本佳美, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Koichiro Kajiura, Hirokazu Takechi and Jun-ichi Seike : 食道癌化学療法におけるEPA強化栄養剤(プロシュア®)導入効果の検討, 第38回日本外科系連合学会学術集会, Jun. 2013.
171.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Koichiro Kajiura, Hirokazu Takechi and Jun-ichi Seike : 好中球リンパ球比は食道癌の予後・効果予測因子となりうる, 第113回日本外科学会定期学術集会, Apr. 2013.
172.	Koichiro Kajiura, Yukikiyo Kawakami, 池田真由美, 古川尊子, 森本雅美, 西野豪志, Masakazu Goto, Misako Nakagawa, Yota Yamamoto, Yoshihito Furukita, Hirokazu Takechi, Yasushi Nakagawa, Mitsuteru Yoshida, Hiromitsu Takizawa, Yukiko Tadokoro, Shoji Sakiyama, Kazuya Kondo and Akira Tangoku : YAGレーザー使用時の気管支鏡破損の1例, 第21回日本呼吸器内視鏡学会中国四国支部会, Feb. 2013.
173.	池田真由美, Hiromitsu Takizawa, 古川尊子, 西野豪志, Masakazu Goto, Koichiro Kajiura, Yasushi Nakagawa, Yukikiyo Kawakami, Mitsuteru Yoshida, Shoji Sakiyama, Kazuya Kondo and Akira Tangoku : 内科的治療抵抗性の乳児気管支肉芽に対してHo:YAGレーザー焼灼術を施行した1例, 第21回日本呼吸器内視鏡学会中国四国支部会, Feb. 2013.
174.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Koichiro Kajiura, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 腹腔鏡下核手術を施行した食道平滑筋腫の1例, 第25回日本内視鏡外科学会総会, Dec. 2012.
175.	坂本晋一, Yoshihito Furukita, Akira Tangoku, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Koichiro Kajiura, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道内分泌細胞癌の2例, 第74回日本臨床外科学会総会, Nov. 2012.
176.	Koichiro Kajiura, Hiromitsu Takizawa, Kazuya Kondo, 池田真由美, 古川尊子, 西野豪志, Masakazu Goto, Yota Yamamoto, Yoshihito Furukita, 森本雅美, Mitsuteru Yoshida, Yasushi Nakagawa, Yukikiyo Kawakami, Shoji Sakiyama and Akira Tangoku : 周術期に骨髄異形成症候群を発症した肺小細胞癌の1例, 第74回日本臨床外科学会総会, Nov. 2012.
177.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Koichiro Kajiura, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌根治手術後の再発症例に対する検討, 第74回日本臨床外科学会総会, Nov. 2012.
178.	Yota Yamamoto, 池田真由美, 古川尊子, 西野豪志, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 食道胃管吻合部の再建術後に生じた難治性消化管皮膚瘻に対し，腸脛靱帯筋膜パッチ，有茎大胸筋皮弁充填術で治癒せしめた一例, 第74回日本臨床外科学会総会, Nov. 2012.
179.	Masakazu Goto, Akira Tangoku, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, 西野豪志, Koichiro Kajiura, Yoshihito Furukita, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌術後早期の血清C-Reactive Protein値は術後縫合不全の予測因子となる, 第74回日本臨床外科学会総会, Nov. 2012.
180.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Koichiro Kajiura, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌手術のリスク評価におけるE-PASSの有用性, 第25回日本外科感染症学会総会学術集会, Nov. 2012.
181.	Yota Yamamoto, 池田真由美, 古川尊子, 森本雅美, 西野豪志, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 第50回日本癌治療学会学術集会, 食道癌周術期における大建中湯投与の有用性の検討, Oct. 2012.
182.	Masakazu Goto, Akira Tangoku, 森本雅美, Koichiro Kajiura, Yoshihito Furukita, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道類基底細胞癌の3切除例, 第67回日本消化器外科学会総会, Jul. 2012.
183.	湊拓也, Yota Yamamoto, 森本雅美, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Jun-ichi Seike, Akira Tangoku and Yoshimi Bando : ALDH1と食道扁平上皮癌の予後に関する検討, 第67回日本消化器外科学会総会, Jul. 2012.
184.	Yota Yamamoto, 森本雅美, Masakazu Goto, Yoshihito Furukita, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 食道亜全摘術時に造設した腸瘻刺入部が要因と考えられる術後腸閉塞の検討, 第67回日本消化器外科学会総会, Jul. 2012.
185.	Yoshihito Furukita, 森本雅美, Masakazu Goto, 湊拓也, Koichiro Kajiura, Yota Yamamoto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 食道癌治療におけるGlasgow prognostic scoreを用いたリスク評価, 第67回日本消化器外科学会総会, Jul. 2012.
186.	仁木亮介, Mitsuo Shimada, Nobuhiro Kurita, Horohiko Sato, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 術前によるMDCTによる右胃動脈, 中結腸静脈把握により安全・確実な腹腔鏡下手術が可能になる, 第112回日本外科学会学術集会, Apr. 2012.
187.	Yoshiyasu Terashima, Mitsuo Shimada, 柏原秀也, Chie Takasu, Masakazu Goto, Tomohiko Miyatani, Jun Higashijima, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka, Horohiko Sato, Takashi Iwata and Nobuhiro Kurita : Short segment Barrett上皮のmalignant potentialの検討∼Activation-induced deaminase(AID)発現とHDAC1-MTA1発現の相関について∼, 第112回日本外科学会学術集会, Apr. 2012.
188.	Motoya Chikakiyo, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也, Chie Takasu and Mitsuo Shimada : 胃癌におけるAID発現は分化型癌の進展に関与する, 第112回日本外科学会学術集会, Apr. 2012.
189.	Masanori Nishioka, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 術前化学放射線療法を併用した腹腔鏡下直腸切除術の肛門機能とQOL, 第112回日本外科学会学術集会, Apr. 2012.
190.	中尾寿宏, Mitsuo Shimada, Nobuhiro Kurita, Horohiko Sato, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : KRAS遺伝子変異からみたTight Junctionを標的とした大腸がんの浸潤転移機構の解明, 第112回日本外科学会学術集会, Apr. 2012.
191.	Masakazu Goto, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也 and Chie Takasu : 大腸癌におけるSirt1発現の低下は内臓肥満と癌進展に関係する, 第112回日本外科学会学術集会, Apr. 2012.
192.	黒田武志, Chie Takasu, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Mitsuo Shimada : 長寿遺伝子Sirtuin familyのSIRT3は胃癌の進展に関与する可能性がある, 第112回日本外科学会学術集会, Apr. 2012.
193.	寺奥大貴, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : Protein Kinase Ciota発現は胃癌の新たな予後予測因子となる, 第112回日本外科学会学術集会, Apr. 2012.
194.	柏原秀也, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto and Chie Takasu : Metabolic surgeryとしてのDuodenal-Jejunal Bypassの有用性に関する研究, 第112回日本外科学会学術集会, Apr. 2012.
195.	Chie Takasu, Keisuke Izumi, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto and 柏原秀也 : カロリー制限は大腸発がんを抑制する可能性がある, 第112回日本外科学会学術集会, Apr. 2012.
196.	Masato Komatsu, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : microRNA233はCell cycleを活性化することで直腸癌化学放射線治療感受性を高める可能性がある, 第112回日本外科学会学術集会, Apr. 2012.
197.	Kouzou Yoshikawa, Chie Takasu, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Mitsuo Shimada : CPT-11はTight Junction障害とTNFα・NF-ҡB経路を介しBacterial Translocationを発症させる, 第112回日本外科学会学術集会, Apr. 2012.
198.	Jun Higashijima, Mitsuo Shimada, Masanori Nishioka, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, Masato Komatsu, Chie Takasu and 柏原秀也 : 大腸癌におけるmicroRNA223発現の意義についての研究(第二報), 第112回日本外科学会学術集会, Apr. 2012.
199.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : ヒストンアセチル化により制御されるCD133とTHBS1発現に基づく胃癌の悪性度評価, 第112回日本外科学会学術集会, Apr. 2012.
200.	Takashi Iwata, Mitsuo Shimada, Chie Takasu, 柏原秀也, Tomohiko Miyatani, Masakazu Goto, Jun Higashijima, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka and Nobuhiro Kurita : 腹腔鏡下幽門側胃切除術Roux-en Y再建の胃閉鎖部に平行な胃空腸吻合は胃排出遅延を克服する, 第112回日本外科学会学術集会, Apr. 2012.
201.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 腹腔鏡補助下胃切除術の定型化と地方におけるTelesurgery mentoring system導入の意義 ―地方における効率的な普及を目指して―, 第112回日本外科学会学術集会, Apr. 2012.
202.	Shinya Morimoto, Mitsuo Shimada, Nobuhiro Kurita, Horohiko Sato, Takashi Iwata, Masanori Nishioka, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 局所進行下部直腸癌に対する術前化学放射線療法併用腹腔鏡下手術の妥当性, 第112回日本外科学会学術集会, Apr. 2012.
203.	Tomohiko Miyatani, Toru Utsunomiya, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Masakazu Goto, 柏原秀也, Chie Takasu and Mitsuo Shimada : 直腸癌に対するDPD阻害フッ化ピリミジンを用いた術前化学放射線療法のrandomized clinical trial ∼個別化治療を目指して∼, 第112回日本外科学会学術集会, Apr. 2012.
204.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Masakazu Goto, Kashihara Hideya and Chie Takasu : Delay of Gastric emptying after Roux-en-Y Reconstruction in Laparoscopy Assisted Distal Gastrectomy., 第84回日本胃癌学会総会, Feb. 2012.
205.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 化学療法著効例に対する外科切除の意義(手術は必要か・いつ手術するか・どこまで切除するか) 高度進行胃癌の集学的治療における外科手術の位置づけ, 日本胃癌学会総会記事, 154, Feb. 2012.
206.	Kouzou Yoshikawa, Mitsuo Shimada, Nobuhiro Kurita, Horohiko Sato, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 腹腔鏡下胃全摘出術の食道空腸吻合法におけるoverlap法のピットホールと再建の工夫, 日本胃癌学会総会記事, 243, Feb. 2012.
207.	Masakazu Goto, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也 and Chie Takasu : 胃癌に対する腹腔鏡下胃切除術の手術成績開腹手術の比較, 日本胃癌学会総会記事, 304, Feb. 2012.
208.	柏原秀也, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto and Chie Takasu : 重篤な心肺腎合併症を有する胃癌手術は安全に施行可能か?, 日本胃癌学会総会記事, 216, 2012.
209.	Masanori Nishioka, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也, Chie Takasu and Masakazu Goto : 大腸癌における細径鉗子を併用した単孔式回盲部切除., 第24回日本内視鏡外科学会総会, Dec. 2011.
210.	Takashi Iwata, Mitsuo Shimada, 柏原秀也, Chie Takasu, Masakazu Goto, Tomohiko Miyatani, Jun Higashijima, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka, Horohiko Sato and Nobuhiro Kurita : 腹腔鏡下胃切除術のトレーニングにおける開腹術からのフィードバックの有用性について., 第24回日本内視鏡外科学会総会, Dec. 2011.
211.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 進行度別に検討した胃癌に対する腹腔鏡下胃切除手術の適応拡大., 第24回日本内視鏡外科学会総会, Dec. 2011.
212.	柏原秀也, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto and Chie Takasu : Protein Kinase Ciota発現は胃癌の新たな予後予測因子となる., 第96回日本消化器病学会四国支部例会/第107回日本消化器内視鏡学会四国地方会, Nov. 2011.
213.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : THBS1発現からみた胃癌腹膜橎種症例に対する個別化治療戦略., 第22回日本消化器癌発生学会総会, Nov. 2011.
214.	Masanori Nishioka, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也, Chie Takasu and Masakazu Goto : Volume Rendering Simulationによる中結腸静脈を意識した腹腔鏡下横行結腸癌手術 (第66回日本大腸肛門病学会学術集会), Journal of the Japan Society of Coloproctology, Vol.64, No.9, 653, Nov. 2011. (Keyword) 結腸腫瘍(外科的療法); 腸間膜静脈; 腹腔鏡法; 横行結腸(外科的療法) / *結腸静脈; 容積表現法 / ヒト; 中年(45∼64); 高齢者(65∼79); 高齢者(80∼); 男; 女
215.	Takashi Iwata, Chie Takasu, 柏原秀也, Masakazu Goto, Tomohiko Miyatani, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka, Horohiko Sato, Nobuhiro Kurita and Mitsuo Shimada : PET-CT，Diffusion MRIを用いたGISTの悪性度診断, Journal of Japan Society of Computer Aided Surgery, Vol.13, No.3, 342-343, Nov. 2011.
216.	Takashi Iwata, Mitsuo Shimada, 柏原秀也, Chie Takasu, Masakazu Goto, Tomohiko Miyatani, Jun Higashijima, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka, Horohiko Sato and Nobuhiro Kurita : 食道胃接合部に存在するshort segment Barrett上皮のmalignant potentialからみた治療戦略について, Journal of Japan Surgical Association, Vol.72, 501, Nov. 2011. (Keyword) Barrett食道; 食道胃接合部; *食道腫瘍 / ヒト
217.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 進行再発胃癌におけるthrombospondin 1(THBS 1)発現の意義個別化治療への展開, Journal of Japan Surgical Association, Vol.72, 483, Nov. 2011. (Keyword) 胃腫瘍(遺伝学,予後,治療); 腫瘍再発; Thrombospondin 1; オーダーメイド医療 / ヒト
218.	柏原秀也, Mitsuo Shimada, Masanori Nishioka, Tomohiko Miyatani, Jun Higashijima, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Chie Takasu and Masakazu Goto : 下部直腸癌に対する術前化学放射線療法併用腹腔鏡下手術とmicroRNAを用いた効果予測, Journal of Japan Surgical Association, Vol.72, 457, Nov. 2011. (Keyword) 直腸腫瘍(薬物療法,放射線療法,外科的療法); 腹腔鏡法; 治療成績; ネオアジュバント療法; MicroRNAs; *放射線化学療法 / ヒト
219.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 腹腔鏡下鼠径ヘルニア修復術(TAPP法)の合併症・再発ポイントとその対策, Journal of Japan Surgical Association, Vol.72, 451, Nov. 2011. (Keyword) 再発; 術後合併症; 鼠径ヘルニア(外科的療法); 腹腔鏡法 / ヒト; 成人(19∼44); 中年(45∼64); 高齢者(65∼79); 高齢者(80∼); 男; 女
220.	Masanori Nishioka, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也, Chie Takasu and Masakazu Goto : 血管分岐バリエーションに対応した腹腔鏡下横行結腸癌手術 (第73回日本臨床外科学会総会), Journal of Japan Surgical Association, Vol.72, 418, Nov. 2011. (Keyword) 結腸腫瘍(外科的療法); 結腸切除; 術前診断; *腹腔鏡法; コンピュータシミュレーション; 横行結腸 / 結腸静脈 / ヒト
221.	Tomohiko Miyatani, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Masakazu Goto, 柏原秀也 and Chie Takasu : 術後深部静脈血栓症予防のための血液抗凝固療法における(第73回日本臨床外科学会総会), Journal of Japan Surgical Association, Vol.72, 364, Nov. 2011. (Keyword) Heparin(治療的利用); Enoxaparin(治療的利用); ランダム化比較試験; 静脈血栓症(予防); Fondaparinux Sodium(治療的利用) / ヒト
222.	Masakazu Goto, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也, Chie Takasu, Toru Utsunomiya, Hidenori Miyake, 和田大助 and 惣中康秀 : 胃癌術前進行度診断における腫瘍マーカーの有用性 (第49回日本癌治療学会学術集会), The Journal of Japan Society for Cancer Therapy, Vol.46, No.2, 794, Oct. 2011. (Keyword) Carcinoembryonic Antigen / 胃腫瘍 / 腫瘍関連糖質抗原 / 腫瘍進行度 / 腫瘍マーカー / 術前診断 / CA-125抗原 / CA-19-9抗原 / CA-72-4抗原 / Homo sapiens
223.	Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也 and Chie Takasu : 胃・大腸癌におけるPrognostic factorとしてのHDAC1・MTA1発現の意義, The Journal of Japan Society for Cancer Therapy, Vol.46, No.2, 656, Oct. 2011. (Keyword) Histone Deacetylases / Repressor Proteins / 胃腫瘍 / 腺腫 / 大腸腫瘍 / ポリープ / Histone Deacetylase 1 / MTA1 Protein / Homo sapiens
224.	Tomohiko Miyatani, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Masakazu Goto, 柏原秀也 and Chie Takasu : 下部直腸癌に対する術前化学放射線療法の適応と腹腔鏡下手術との併用 (第49回日本癌治療学会学術集会), The Journal of Japan Society for Cancer Therapy, Vol.46, No.2, 570, Oct. 2011. (Keyword) 直腸腫瘍 / 腹腔鏡法 / ネオアジュバント療法 / TS-1 / 放射線化学療法 / Homo sapiens
225.	Masakazu Goto, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, 柏原秀也, Chie Mikami, Toru Utsunomiya and Hidenori Miyake : 胃癌における悪性度指標としてAID(activation-induced cytidine deaminase)発現の意義., JDDW(日本消化器関連学会集会)【第53回日本消化器病学会，第82回日本消化器内視鏡学会総会，第15回日本肝臓学会大会，第9回日本消化器外科学会】, Oct. 2011.
226.	Horohiko Sato, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Tomohiko Miyatani, Masakazu Goto, 柏原秀也, Chie Mikami and Toru Utsunomiya : 肥満指標と胃・大腸癌進展との相関に関する検討., JDDW(日本消化器関連学会集会)【第53回日本消化器病学会，第82回日本消化器内視鏡学会総会，第15回日本肝臓学会大会，第9回日本消化器外科学会】, Oct. 2011.
227.	Takashi Iwata, Mitsuo Shimada, 小松正人, 柏原秀也, Chie Takasu, Masakazu Goto, Tomohiko Miyatani, Jun Higashijima, Kouzou Yoshikawa, Shinya Morimoto, Masanori Nishioka, Horohiko Sato and Nobuhiro Kurita : ヒト脂肪由来幹細胞は膵癌，大腸癌細胞の増殖を抑制する., 第29回日本ヒト細胞学会学術集会, Aug. 2011.
228.	Masakazu Goto, 三浦連人, 木下貴史, 松山和男, Tadaoki Morimoto, Masanori Nishioka, Mitsuo Shimada and Seiki Tashiro : 下部直腸癌に対する術前化学放射線療法の効果 (第66回日本消化器外科学会総会), 日本消化器外科学会総会, 841, Jul. 2011. (Keyword) 直腸腫瘍 / 治療成績 / ネオアジュバント療法 / 放射線化学療法 / Homo sapiens
229.	Tomohiko Miyatani, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Horohiko Sato, Masanori Nishioka, Shinya Morimoto, Kouzou Yoshikawa, Jun Higashijima, Masakazu Goto, 柏原秀也 and Chie Takasu : 大腸癌肝転移症例における新たな細分類に関する検討., 第75回大腸癌研究会, Jul. 2011.

Et cetera, Workshop:

1.	Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 髙杉遥, 細川暉雄, Sawaka Yukishige, Taihei Takeuchi, Tomohiro Inui, Hiroyuki Sumitomo, Naoki Miyamoto, Shin-ichi Sakamoto, Souichiro Sasa, Atsushi Morishita, Mariko Aoyama, Hiroaki Inoue, Naoya Kawakita, Hiroaki Toba and Hiromitsu Takizawa : 当院における腹臥位胸腔鏡下食道亜全摘術の術後短期成績について, 第36回四国内視鏡外科研究会, Mar. 2024.
2.	Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 髙杉遥, 細川暉雄, 竹内大平, Hiroyuki Sumitomo, Atsushi Morishita, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 腹臥位胸腔鏡下食道亜全摘術の術後短期成績について, 第44回四国食道疾患研究会学術講演会, Feb. 2024.
3.	Satoshi Fujiwara, Masakazu Goto, Seiya Inoue, 髙杉遥, 細川暉雄, 竹内大平, Hiroyuki Sumitomo, Atsushi Morishita, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後の再発症例の検討, 第44回四国食道疾患研究会学術講演会, Feb. 2024.
4.	Seiya Inoue, Masakazu Goto, Satoshi Fujiwara, 髙杉遥, 細川暉雄, 竹内大平, Hiroyuki Sumitomo, Atsushi Morishita, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 吻合部トラブル回避のわれわれの工夫 ∼吻合法の比較検討∼, 第44回四国食道疾患研究会学術講演会, Feb. 2024.
5.	髙杉遥, Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 細川暉雄, 竹内大平, Hiroyuki Sumitomo, Atsushi Morishita, Mariko Aoyama, Hiroaki Toba and Hiromitsu Takizawa : 食道胃接合部癌における術式別短期成績の比較, 第44回四国食道疾患研究会学術講演会, Feb. 2024.
6.	細川暉雄, Mariko Aoyama, 竹内大平, Tomohiro Inui, 髙杉遥, Shin-ichi Sakamoto, Hiroyuki Sumitomo, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : レンバチニブ内服中に間質性肺炎をきたした甲状腺低分化癌の一例, 第52回中国四国甲状腺外科研究会, Feb. 2024.
7.	Shin-ichi Sakamoto, Mariko Aoyama, 細川暉雄, 竹内大平, 髙杉遥, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : Dynamic CTが局在診断に有用であった原発性副甲状腺機能亢進症の2例, 第52回中国四国甲状腺外科研究会, Feb. 2024.
8.	Mariko Aoyama, 細川暉雄, 竹内大平, 髙杉遥, Shin-ichi Sakamoto, Naoki Miyamoto, Atsushi Morishita, Seiya Inoue, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba, Yoshimi Bando, Hisanori Uehara and Hiromitsu Takizawa : 穿刺吸引細胞への免疫染色併用が術前診断に有用であった2症例, 第52回中国四国甲状腺外科研究会, Feb. 2024.
9.	Satoshi Fujiwara, 井﨑富由実, 竹内大平, 住友弘幸, Seiya Inoue, Masakazu Goto and Hiromitsu Takizawa : 食道癌手術における胃管作成に対する術式の検討, 第35回四国内視鏡外科研究会, Feb. 2023.
10.	竹内大平, Seiya Inoue, 井﨑富由実, Hiroyuki Sumitomo, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後に急激な経過を辿った緑膿菌肺炎の1例, 第6回徳島外科医会, Feb. 2023.
11.	三崎万理子, 井﨑富由実, 竹内大平, Shin-ichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : レンバチニブ投与後に切除し得た局所進行甲状腺乳頭癌の1例, 第6回徳島外科医会, Feb. 2023.
12.	住友弘幸, Masakazu Goto, Seiya Inoue, Satoshi Fujiwara, 井﨑富由実, 行重佐和香, 竹内大平, Tomohiro Inui, Shin-ichi Sakamoto, Naoki Miyamoto, Souichiro Sasa, 三崎万理子, Hiroaki Inoue, Mika Takashima, Naoya Kawakita, Kazumasa Okumura, Hiroaki Toba and Hiromitsu Takizawa : 食道癌術後，再建胃管穿孔による右膿胸を生じた1例, 第6回徳島外科医会, Feb. 2023.
13.	Satoshi Fujiwara, 井﨑富由実, 行重佐和香, 竹内大平, Hiroyuki Sumitomo, Seiya Inoue, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 食道癌手術における胃管作成に対する術式の検討, 第43回四国食道疾患研究会学術講演会, Jan. 2023.
14.	Seiya Inoue, 井﨑富由実, 行重佐和香, 竹内大平, Hiroyuki Sumitomo, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 術後補助療法としてのNivolumabの可能性, 第43回四国食道疾患研究会学術講演会, Jan. 2023.
15.	井﨑富由実, Masakazu Goto, 行重佐和香, 竹内大平, Tomohiro Inui, Hiroyuki Sumitomo, Satoshi Fujiwara, Seiya Inoue, Hiroaki Toba and Hiromitsu Takizawa : 食道蠕動運動障害を伴う横隔膜上食道憩室に対して腹腔鏡下手術を施行した1例, 第43回四国食道疾患研究会学術講演会, Jan. 2023.
16.	竹内大平, Seiya Inoue, 井﨑富由実, 行重佐和香, Hiroyuki Sumitomo, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 食道癌根治術後に急激な経過を辿った緑膿菌肺炎の一例, 第43回四国食道疾患研究会学術講演会, Jan. 2023.
17.	井﨑富由実, Hiroaki Inoue, Tomohiro Inui, Souichiro Sasa, Mariko Aoyama, Naoki Miyamoto, Kazumasa Okumura, Hiroaki Toba, Masakazu Goto, 住田智志, Yoshimi Bando and Hiromitsu Takizawa : 巨大石灰化を認めた骨・軟骨化生を伴う乳癌の1例, 第19回日本乳癌学会中国四国地方会, Sep. 2022.
18.	青山理央, Souichiro Sasa, Tomohiro Inui, Mariko Aoyama, Kazumasa Okumura, Hiroaki Inoue, Hiroaki Toba, Masakazu Goto, Takeshi Oya and Hiromitsu Takizawa : 乳腺腺様嚢胞癌の一例, 第19回日本乳癌学会中国四国地方会, Sep. 2022.
19.	Mika Takashima, Hiroaki Toba, Shinichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Takahiro Yoshida, Jun-ichi Seike, Yukikiyo Kawakami, Kazuya Kondo and Hiromitsu Takizawa : 進行食道癌による気道のEmergencyに対する気道ステント留置例の検討, 第5回徳島外科医会, Feb. 2022.
20.	Mariko Aoyama, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当院でのBasedow病に対する内視鏡下甲状腺手術についての治療成績, 第5回徳島外科医会, Feb. 2022.
21.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Hiroaki Toba, Akira Tangoku and Hiromitsu Takizawa : 安全な食道再建のわれわれの工夫, 第5回徳島外科医会, Feb. 2022.
22.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Akira Tangoku, Hiroaki Toba and Hiromitsu Takizawa : 食道切除後再建術における最近の取り組み-ICG血流評価法とCollard変法の有用性-, 第42回四国食道疾患研究会(WEB開催), Feb. 2022.
23.	Satoshi Fujiwara, Takahiro Yoshida, Masakazu Goto, Seiya Inoue, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Mariko Aoyama, Akira Tangoku, Hiroaki Toba and Hiromitsu Takizawa : 肺癌を合併した食道癌に対し，一期的手術を施行した3例の検討, 第42回四国食道疾患研究会(WEB開催), Feb. 2022.
24.	Mariko Aoyama, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Seiya Inoue, Naoya Kawakita, Satoshi Fujiwara, Masakazu Goto, Hiroaki Toba and Hiromitsu Takizawa : 当院でのBasedow病に対する内視鏡下甲状腺手術についての治療成績, 第50回中国四国甲状腺外科研究会, Feb. 2022.
25.	Hidenori Maki, Seiya Inoue, 南城和正, 庄野隆志, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida and Akira Tangoku : 巨大食道裂孔ヘルニアを伴う特発性食道破裂の一例, 第4回徳島外科医会, Feb. 2021.
26.	南城和正, Seiya Inoue, Hidenori Maki, 庄野隆志, Takeshi Nishino, Masakazu Goto, Takahiro Yoshida and Akira Tangoku : 食道癌術後に門脈ガス血症・腸管気腫症を発症した1例, 第4回徳島外科医会, Feb. 2021.
27.	Hidenori Maki, Seiya Inoue, 南城和正, Masakazu Goto, Takeshi Nishino, Takahiro Yoshida and Akira Tangoku : 巨大食道裂孔ヘルニアを伴った特発性食道破裂の一例, 第41回四国食道疾患研究会(Web開催), Jan. 2021.
28.	山本清成, Takeshi Nishino, 庄野隆志, 南城和正, Hidenori Maki, 宮本直輝, Mika Takashima, Daisuke Matsumoto, Naoya Kawakita, Seiya Inoue, Masakazu Goto, Takahiro Yoshida, Hiroaki Toba, Mitsuteru Yoshida, Hiromitsu Takizawa and Akira Tangoku : 気管分岐部狭窄を伴う進行食道癌に対する集学的治療の経験, 第261回徳島医学会学術集会(Web配信), Aug. 2020.
29.	庄野隆志, Takeshi Nishino, 南城和正, 山本清成, Hidenori Maki, Tomohiro Inui, Soichiroh Sasa, Mariko Aoyama, Hiroaki Inoue, Seiya Inoue, Masakazu Goto, Kazumasa Okumura, Takahiro Yoshida and Akira Tangoku : 乳癌術後20年目に食道転移をきたした1例, 第261回徳島医学会学術集会(Web配信), Aug. 2020.
30.	Hiroaki Toba, Hiromitsu Takizawa, 庄野隆志, 南城和正, 山本清成, Hidenori Maki, Tomohiro Inui, Shinichi Sakamoto, Naoki Miyamoto, Soichiroh Sasa, Mariko Aoyama, Hiroaki Inoue, Mika Takashima, Daisuke Matsumoto, Seiya Inoue, Naoya Kawakita, Masakazu Goto, Takeshi Nishino, Kazumasa Okumura, Takahiro Yoshida, Yukikiyo Kawakami, Mitsuteru Yoshida, Kazuya Kondo and Akira Tangoku : より良いがんの地域連携体制構築のための取り組み, 第261回徳島医学会学術集会(Web配信), Aug. 2020.
31.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, 鈴木恵美, 山田亮, Soichiroh Sasa, Masakazu Goto, Hirokazu Takechi and Akira Tangoku : 食道癌に対する縦隔鏡下食道癌根治術∼縦隔鏡操作と経裂孔操作の連携による縦隔リンパ節郭清の工夫∼, 第39回四国食道疾患研究会, Jan. 2019.
32.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, 鈴木恵美, 山田亮, Soichiroh Sasa, Masakazu Goto, Hirokazu Takechi and Akira Tangoku : 術後乳糜瘻に対する鼠径リンパ節アプローチによるリンパ管造影の有用性の検討, 第39回四国食道疾患研究会, Jan. 2019.
33.	Takeshi Nishino, Takahiro Yoshida, Masakazu Goto, Seiya Inoue, 青山万理子, 行重佐和香, 森本雅美, Hirokazu Takechi and Akira Tangoku : 縦隔鏡下食道癌根治術を目指したラーニングステップとしての縦隔鏡・胸腔鏡ハイブリッド手術, 第38回四国食道疾患研究会, Feb. 2018.
34.	Masakazu Goto, Takahiro Yoshida, Takeshi Nishino, Seiya Inoue, 青山万理子, 行重佐和香, 森本雅美, Hirokazu Takechi and Akira Tangoku : 縦隔鏡下食道切除術における経裂孔的アプローチに必要な解剖, 第38回四国食道疾患研究会, Feb. 2018.
35.	Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, 青山万理子, 行重佐和香, 森本雅美, Hirokazu Takechi and Akira Tangoku : CTリンパ管造影を用いた表在型食道癌におけるリンパ節転移診断と治療成績, 第38回四国食道疾患研究会, Feb. 2018.
36.	髙杉遥, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, 松本大資, 乾友浩, 都築英雄 and Akira Tangoku : A case of advanced colon cancer arising from a colon graft for an esophago-bronchial fistula, 第38回四国食道疾患研究会, Feb. 2018.
37.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, 青山万理子, 行重佐和香, 森本雅美, Hirokazu Takechi and Akira Tangoku : 食道癌におけるEGFR, HER-2発現の意義, 第38回四国食道疾患研究会, Feb. 2018.
38.	Takeshi Nishino, Takahiro Yoshida, Seiya Inoue, Masakazu Goto, Hirokazu Takechi, Jun-ichi Seike and Akira Tangoku : 縦隔鏡下食道癌根治術を目指した縦隔鏡・胸腔鏡ハイブリッド手術, 第32回四国内視鏡外科研究会, Feb. 2018.
39.	行重佐和香, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Seiya Inoue, Akira Tangoku, Hisanori Uehara and Akiko Yoneda : 食道アカラシアに合併した食道扁平上皮癌に対する食道亜全摘術の1例, 2017年度徳島外科医会, Feb. 2018.
40.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 好中球リンパ球比は食道癌化学療法の効果予測因子となりうる, 第34回癌免疫外科研究会, May 2013.
41.	坂本晋一, Yoshihito Furukita, Akira Tangoku, 宮本佳美, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 初期治療が奏効するも不良な転帰を辿った食道内分泌細胞癌の2例, 第33回四国食道疾患研究会, Feb. 2013.
42.	西野豪志, Yota Yamamoto, 池田真由美, 古川尊子, Masakazu Goto, Yoshihito Furukita, 湯浅康弘, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道扁平上皮癌に対する術前DFP療法(weeklyDOC+low-doseFP)の有用性, 第33回四国食道疾患研究会, Feb. 2013.
43.	Yota Yamamoto, 坂本晋一, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yoshihito Furukita, 湯浅康弘, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道亜全摘術後の長期的体重変化の検討, 第33回四国食道疾患研究会, Feb. 2013.
44.	Yoshihito Furukita, Akira Tangoku, 坂本晋一, 宮本佳美, 池田真由美, 古川尊子, 森本雅美, Masakazu Goto, 西野豪志, Yota Yamamoto, Hirokazu Takechi and Jun-ichi Seike : 食道癌手術のリスク評価におけるE-PASSの有用性, 第33回四国食道疾患研究会, Feb. 2013.
45.	Masakazu Goto, 坂本晋一, 池田真由美, 古川尊子, 西野豪志, 湊拓也, Koichiro Kajiura, Yoshihito Furukita, Yota Yamamoto, 湯浅康弘, Hirokazu Takechi, Takahiro Yoshida, Jun-ichi Seike and Akira Tangoku : 食道癌術後吻合部狭窄症例の検討, 第33回四国食道疾患研究会, Feb. 2013.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

食道癌に対するPD-1阻害薬とケモカイン治療併用による抗腫瘍効果増強に関する研究 (Project/Area Number: 23K15477 )
人工知能を用いた食道癌の気管・気管支浸潤の診断ー診断基準の確立ー (Project/Area Number: 22K08804 )
Personalized treatment for esophageal cancer using detailed examination of biopsy spacemen (Project/Area Number: 17K10514 )
Experimental analysis of the factors which predict the prognosis and the efficacy of preoperative systemic chemotherapy with taxane for esophageal cancer (Project/Area Number: 24591945 )
Search by Researcher Number (00437659)

Associate Professor : Goto, Masakazu

Research

Personal Web Page

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)